FCGR3A-mediated phagocytosis (Homo sapiens)

From WikiPathways

Jump to: navigation, search
6, 604121, 3624, 284, 27, 50, 53, 57...3, 20, 543130, 3348, 632, 12, 13, 16, 37...26, 51, 599, 17, 38, 55, 58...34, 641, 42, 46, 56398, 394132, 62549, 5825, 3118, 40, 5119, 4572210, 11, 23, 29, 35...4, 27, 50, 53, 57...5, 14-16, 43HostLeishmaniacytosolcytosolphagocytic cupIg kappa chain V-I region DEE Ig lambda chain V-I region HA Ig lambda chain V-IV region Kern CYFIP2 IGLC6 ACTR2 Ig heavy chain V-III region CAM Ig heavy chain V-II region OU Ig lambda chain V-IV region Bau Ig kappa chain V-I region Daudi Ig heavy chain V-III region WEA IGKV2-28 Ig kappa chain V-I region Daudi p-Y160,Y171-CD3G Ig heavy chain V-III region JON Ig kappa chain V-II region RPMI 6410 IGLV2-33(1-?) Ig kappa chain V-I region Wes IGLV3-27(1-?) Ig lambda chain V-VI region AR ACTR3 IGLV11-55(1-?) IGLV11-55(1-?) Ig heavy chain V-III region JON WIPF1 IGLV3-16(1-?) NCK1 IGKV1-5(23-?) IGLV1-44(1-?) IGHV7-81(1-?) BAIAP2Ig kappa chain V-I region AG FCGR3A G-actinIGLV2-33(1-?) IGLV1-40(1-?) Ig kappa chain V-I region Gal Ig heavy chain V-III region CAM WAVE2, WASP, N-WASPIGKV3D-20 IGLV3-27(1-?) ARPC1B IGLV3-12(1-?) Ig heavy chain V-III region WEA IGHV(1-?) GTPIGLV2-18(1-?) IGLV3-22(1-?) IGLV2-11(1-?) IGLV(23-?) Ig kappa chain V region EV15 Ig kappa chain V-III region B6 GTP Ig lambda chain V-II region TOG NCKAP1L MYO10 Ig lambda chain V-IV region Hil IGLV3-22(1-?) Ig lambda chain V region 4A ARPC1B p-Y160,Y171-CD3G Ig kappa chain V-III region B6 Ig heavy chain V-II region ARH-77 IGLV(23-?) Ig lambda chain V-II region MGC Ig heavy chain V-II region NEWM Ig kappa chain V-II region FR IGHG2 IGHG2 IGLV4-3(1-?) IGLC6 IGLV5-45(1-?) CYFIP2 p-Y151-WASF1 GDP Ig kappa chain V-III region VG IGLV10-54(1-?) Ig heavy chain V-II region OU IGLV1-36(1-?) Ig kappa chain V-III region B6 p-Y256-WASL ACTG1 NCKIPSD PI(3,4)P2 IGLV2-18(1-?) IGLV7-43(1-?) Ig lambda chain V-IV region Kern BAIAP2 IGLV2-18(1-?) F-actinIg kappa chain V-I region HK101 Ig kappa chain V-I region Gal IGHV7-81(1-?) Ig kappa chain V-I region AG IGKV2-28 IGKV4-1(21-?) Ig heavy chain V-I region EU Ig heavy chain V-III region KOL IGLC3 PI(4,5)P2 IGLV5-45(1-?) IGLV4-69(1-?) IGLV3-16(1-?) IGLV5-37(1-?) Ig kappa chain V-I region Wes Ig kappa chain V-I region BAN IGHV7-81(1-?) Ig lambda chain V region 4A Ig lambda chain V-III region LOI IGLC1 ACTB(1-375) IGLV4-69(1-?) ELMO2 IGLV4-3(1-?) Ig lambda chain V-I region NEW Ig heavy chain V-III region BRO CDC42 CDC42 Ig lambda chain V region 4A Ig heavy chain V-III region BUT Ig lambda chain V-III region LOI ARPC1A IGLV1-40(1-?) Ig heavy chain V-II region NEWM GDPIg lambda chain V-IV region Hil Ig kappa chain V-I region BAN IGLV2-23(1-?) IGLC2 IGLV11-55(1-?) Ig heavy chain V-I region HG3 Ig heavy chain V-II region ARH-77 FYN WASF3 Ig lambda chain V-II region BOH WIPF2 Ig lambda chain V-IV region Kern ARPC1B Ig lambda chain V-IV region Kern IGLV8-61(1-?) IGLC7 p-T202,Y204-MAPK3 Ig heavy chain V-III region BUT Ig kappa chain V-II region FR ACTB(1-375) IGLC2 Ig kappa chain V-III region B6 IGLV2-33(1-?) IGKV3D-20 Ig heavy chain V-III region DOB IgH heavy chain V-III region VH26 precursor Ig lambda chain V-VI region AR LPG1G2 ACTR2 PI(4,5)P2 IGLV1-44(1-?) IGHV(1-?) ARPC1A F-actin Ig kappa chain V-I region Gal p-T,Y MAPK dimersIg kappa chain V-I region HK101 RAC1 Ig heavy chain V-III region JON p-Y150,S343,T346-WASF2 WIPF2 BAIAP2 ACTR2 IGHV(1-?) ADP Ig kappa chain V-III region POM IGLV11-55(1-?) p-Y291-WAS Ig kappa chain V-I region AU Ig lambda chain V-II region TOG Ig kappa chain V-III region VG PTK2 IGHV1-2 Lma amastigote surface Ig kappa chain V-I region Wes IGLV1-44(1-?) IGLV3-22(1-?) Ig heavy chain V-III region BUT Ig heavy chain V-III region CAM Ig heavy chain V-I region HG3 ARPC3 ARPC2 Ig heavy chain V-III region CAM Ig heavy chain V-II region MCE Ig heavy chain V-II region ARH-77 Ig heavy chain V-II region ARH-77 Ig kappa chain V-II region RPMI 6410 VAV3 Ig lambda chain V-VI region AR VAV3 Motherfilament:branchingcomplex:daughterfilamentIg kappa chain V-II region FR RAC1 PiIg lambda chain V-I region NEWM IGLV3-27(1-?) IGLC7 ACTG1 Ig heavy chain V-III region KOL Ig lambda chain V region 4A FCGR3A IGLV5-37(1-?) Ig kappa chain V-I region HK101 Ig kappa chain V-II region FR IGHG1 IGLV7-46(1-?) WIPF1 Ig lambda chain V region 4A IGLV2-33(1-?) MYH2 Ig lambda chain V-IV region Kern BTK IGKV2D-30 Ig heavy chain V-III region BUT IGKV1-5(23-?) Ig lambda chain V-II region NEI IGKV3D-20 IGHG4 Ig heavy chain V-I region EU IGKVA18(21-?) F-actin Ig lambda chain V-I region HA IGHV1-2 IGLV5-45(1-?) Ig lambda chain V-I region HA IGHG3 IGKV1-12 Ig heavy chain V-III region TRO Ig heavy chain V-III region KOL IGLV3-12(1-?) Ig kappa chain V-II region FR MYO5A PI(3,4,5)P3 IGLC2 IGLV7-43(1-?) PI(4,5)P2 Ig kappa chain V-II region Cum RAC1 Ig lambda chain V-I region HA IGHG1 p-6Y-CD247 IGLV2-11(1-?) IGLV2-23(1-?) VAV3 Ig heavy chain V-III region BUT IGHG1 IGLV8-61(1-?) IGLC2 IGHG3 IGLV1-36(1-?) Ig kappa chain V-III region POM ACTR3 IGKC IgH heavy chain V-III region VH26 precursor Ig kappa chain V-III region B6 IGLV4-69(1-?) p-6Y-CD247 IGLV1-40(1-?) IGLV2-11(1-?) SYK IGKV1-5(23-?) Ig lambda chain V-IV region Kern IGLV7-46(1-?) ACTR2 Ig heavy chain V-II region MCE ABI2 Ig lambda chain V-I region NEWM Ig lambda chain V-III region SH IGHV1-2 IGKV4-1(21-?) IGKV2-28 IGLV5-37(1-?) Ig lambda chain V-IV region Hil WIPF2 Ig lambda chain V-II region NEI Ig heavy chain V-III region JON IGHV(1-?) Ig heavy chain V-III region JON IGLV3-12(1-?) IGHG4 IGLV7-43(1-?) ADPARPC4 IGKV4-1(21-?) Ig heavy chain V-III region TRO NCK1 Ig kappa chain V-I region AU IGLV5-45(1-?) Ig lambda chain V-III region LOI IGLC1 Ig heavy chain V-III region BRO p-Y151,S,T-WASF3 IGLC2 F-actin ACTG1 SH3 domain proteinsIg heavy chain V-III region WEA CD247-1 Ig lambda chain V-IV region Hil IGLV4-60(1-?) ACTB(1-375) Ig heavy chain V-III region JON IGLC1 IGKV1-12 Ig heavy chain V-II region NEWM Ig heavy chain V-II region WAH IgGIGKV2D-30 Ig kappa chain V-II region RPMI 6410 RAC1 IGKV2-28 Ig kappa chain V region EV15 Ig kappa chain V-I region Daudi Ig lambda chain V-I region VOR Ig kappa chain V-I region BAN IGLV5-45(1-?) IGLV2-33(1-?) RAC1 IGLV10-54(1-?) Ig lambda chain V-II region TOG IGLV4-69(1-?) IGLV2-18(1-?) IGLV7-43(1-?) Ig kappa chain V-III region VG Lma amastigote surface IGKV3D-20 ARPC3 PI(4,5)P2 Ig kappa chain V-I region Daudi IGLV3-27(1-?) FCGR3A IGLV(23-?) p-Y291-WAS IGHV7-81(1-?) LPG1G2 IGKV2-28 Ig kappa chain V-II region Cum LPG1G2 IGLC2 VAV1 IGHG1 CDC42 Ig kappa chain V-I region Gal IGLV10-54(1-?) Ig lambda chain V-VI region AR IGLV8-61(1-?) Ig heavy chain V-II region WAH ABI1 MYO1C IGKV4-1(21-?) IGHV7-81(1-?) IGLV1-44(1-?) IGLC6 IGLV1-36(1-?) IGLV3-22(1-?) IGHG2 Ig kappa chain V-I region Wes IGLV10-54(1-?) Ig lambda chain V-II region MGC Unknown GEFIg kappa chain V-I region Gal IGLV2-11(1-?) IGLV4-3(1-?) ADPp-Y172-VAV2 IGHV(1-?) IGLV3-12(1-?) Ig heavy chain V-III region JON IGLC2 MYO1C Ig kappa chain V-I region HK101 Ig kappa chain V-III region B6 IGHV1-2 WAVE2, WASP,N-WASP:ARP2/3complex:G-actinIGKVA18(21-?) IGLV4-69(1-?) IGHV(1-?) p-Y291-WAS IGLV(23-?) Ig lambda chain V-VI region AR PI(4,5)P2IGLV2-18(1-?) p-6Y-CD247 IGLV11-55(1-?) IGLV8-61(1-?) IGLV1-40(1-?) IGLV2-11(1-?) RAC1 ACTR2 IGHG1 IGLV3-12(1-?) IGLC7 LPG1G2 Ig heavy chain V-III region DOB CDC42:GTPIg lambda chain V-II region TOG IGHV(1-?) GTP Lma amastigote surface WIPF2 Ig lambda chain V-II region BOH Ig lambda chain V-I region HA Ig kappa chain V-III region VG Ig heavy chain V-III region DOB IGLV1-40(1-?) Ig kappa chain V-I region HK101 IGLV8-61(1-?) ACTG1 ARPC2 PI(4,5)P2:WASP/N-WASPIg lambda chain V-III region LOI IGLV1-44(1-?) ABI1 Ig kappa chain V-I region Wes WAVE RegulatoryComplexIGKV4-1(21-?) IGKV2-28 NCKAP1 ARPC1B Ig heavy chain V-II region NEWM IGHG4 Ig heavy chain V-III region JON p-6Y-SYK ATP IGKV1-12 IGLV5-45(1-?) Ig heavy chain V-III region CAM WAS NCKIPSD Ig kappa chain V-II region Cum Ig kappa chain V-I region AU IGLV3-16(1-?) IGKV4-1(21-?) p-Y151,S,T-WASF3 PiIGLV3-25(1-?) IGKV2-28 Ig kappa chain V region EV15 ARPC1B Ig kappa chain V-I region BAN p-Y151,S,T-WASF1 CYFIP2 IGLV4-60(1-?) Ig heavy chain V-III region CAM Ig lambda chain V-IV region Kern MyosinIg lambda chain V-IV region Hil Ig heavy chain V-III region KOL PI(3,4,5)P3Ig lambda chain V-I region VOR Ig kappa chain V-II region Cum PI(3,4,5)P3 GDP ABI2 WAS Ig lambda chain V-IV region Hil IGKV3D-20 CYFIP1 Ig lambda chain V-II region MGC Ig kappa chain V-I region BAN p-Y150,S343,T346-WASF2 Ig lambda chain V-I region VOR Ig heavy chain V-III region JON Ig lambda chain V region 4A ATPIGLV2-11(1-?) IGKVA18(21-?) Lma amastigote surface IGLV3-12(1-?) IGLV1-36(1-?) IGKVA18(21-?) IGLV7-46(1-?) Ig kappa chain V-II region Cum Ig lambda chain V-II region TOG Ig kappa chain V-I region DEE Ig heavy chain V-III region DOB VAV2 p-Y150,S343,T346-WASF2 IGHV7-81(1-?) SRC-1 IGKV1-5(23-?) IGLV5-37(1-?) CYFIP1 IGLV3-27(1-?) ARP2/3 complex (ATPbound)Ig lambda chain V-IV region Kern IGLV2-33(1-?) Ig heavy chain V-II region WAH IGLC6 Ig heavy chain V-II region WAH IGLV7-43(1-?) Ig lambda chain V-II region BOH Ig lambda chain V-IV region Hil Ig kappa chain V-III region B6 WIPF1 Lma amastigote surface IGLV2-23(1-?) IGLV2-11(1-?) Ig lambda chain V-IV region Bau IGLC3 FCGR3A p-Y150-WASF2 Ig lambda chain V-VI region AR IGHG2 IgG:Lmaantigens:FCGR3A:CD3dimersIg lambda chain V-II region TOG IGHG3 ATPIg heavy chain V-III region BUT IGLC3 Ig heavy chain V-III region TRO IGLV2-18(1-?) IGLV5-37(1-?) Ig lambda chain V-III region SH Ig heavy chain V-II region WAH IGLV2-23(1-?) IGHG2 Ig heavy chain V-II region OU Ig kappa chain V-I region BAN IGKVA18(21-?) p-4S-ABI2 p-Y150-WASF2 p-Y151-WASF1 PI(3,4,5)P3 IGHG3 Ig lambda chain V-II region NEI FCGR3A IGLC3 IGHV(1-?) IGLV5-37(1-?) CDC42:GTP:WASP/N-WASPIGLV(23-?) Ig kappa chain V-I region DEE Ig kappa chain V-I region Wes IGHG4 IGLV3-25(1-?) ATP IGLV3-16(1-?) Ig kappa chain V-I region AU IGHG3 IGHV1-2 Ig kappa chain V-I region BAN Ig heavy chain V-III region TRO Ig kappa chain V-I region Gal ARPC5 IGLV3-25(1-?) Ig heavy chain V-II region OU Ig kappa chain V-I region AG IGHV7-81(1-?) WIPF3 IGKV1-5(23-?) ACTR2 Ig kappa chain V-I region BAN IGKV1-5(23-?) Ig heavy chain V-II region MCE Ig heavy chain V-I region EU CDC42 p-Y151-WASF3 ARPC3 p-Y151-WASF3 Ig lambda chain V-IV region Bau IGLV4-60(1-?) BRK1 Ig heavy chain V-II region NEWM IgH heavy chain V-III region VH26 precursor GTP Ig lambda chain V-I region VOR IGHG4 GTP IGLV2-23(1-?) Ig lambda chain V-I region NEW IGLC6 CDC42 LPG1G2IGLV7-43(1-?) p-Y,S,T-WRC:IRSp53/58:RAC1:GTP:PIP3IGLV1-44(1-?) IGHG1 IGKV3D-20 IgH heavy chain V-III region VH26 precursor PI(3,4,5)P3 NCKAP1L IGLC3 Ig kappa chain V-III region POM IGHG1 p-Y151-WASF3 Ig heavy chain V-II region OU IGHG1 IGKV4-1(21-?) IGLV1-36(1-?) Ig lambda chain V-IV region Bau IGHG4 IGLV4-69(1-?) WASF3 FCGRIIIA:CD3G/CD3ZdimersIGKVA18(21-?) IGLV(23-?) NCKAP1L Ig heavy chain V-II region OU IGLC1 Ig kappa chain V-I region Gal WASF1 IGLV7-46(1-?) IGLV2-18(1-?) Ig kappa chain V-I region Wes FGR Ig lambda chain V region 4A IGLV7-43(1-?) Ig heavy chain V-II region MCE VAV1 IGLC1 WIPF3 ARPC5 BAIAP2 IGLV8-61(1-?) ARPC1A MYH2 Ig heavy chain V-III region CAM Ig kappa chain V-I region DEE IGLV3-25(1-?) p-Y151,S,T-WASF1 Ig heavy chain V-II region ARH-77 CRK IGHG2 Ig heavy chain V-II region WAH Ig kappa chain V-I region AG Ig heavy chain V-III region TRO IGLV5-45(1-?) IGLC3 Ig kappa chain V-III region VG IGLV3-25(1-?) IGLV1-44(1-?) IGLV3-22(1-?) Ig kappa chain V region EV15 IGKV4-1(21-?) ABI1 Ig heavy chain V-II region WAH Ig lambda chain V region 4A Ig heavy chain V-III region CAM ATP ATP ATPIGLV10-54(1-?) Ig kappa chain V-II region RPMI 6410 IGLV(23-?) Ig kappa chain V-I region Wes BAIAP2 Ig kappa chain V-III region VG IGLC2 NCKAP1L IGHG1 Ig kappa chain V region EV15 FCGR3A IGKV3D-20 Ig kappa chain V-I region AG Ig kappa chain V-I region AU Ig kappa chain V-I region HK101 Ig kappa chain V-I region HK101 Ig heavy chain V-I region HG3 IgH heavy chain V-III region VH26 precursor Ig kappa chain V-II region Cum IGHG2 CRK:DOCK180:ELMO1,ELMO2IGLV3-22(1-?) ATP Ig kappa chain V-III region POM IGLV3-27(1-?) FCGR3A IGLV4-60(1-?) ARPC1A PI(4,5)P2 Ig kappa chain V-II region FR Ig kappa chain V-I region Daudi F-actin IGLV1-40(1-?) Ig heavy chain V-II region NEWM NCK1 Ig heavy chain V-III region WEA Ig lambda chain V-I region VOR IGKV2D-30 Ig heavy chain V-III region KOL Ig heavy chain V-I region EU Ig lambda chain V region 4A Ig lambda chain V-I region VOR IGHG3 Ig lambda chain V-III region LOI ADPIGLC6 WIPF1 Ig kappa chain V-I region Gal Ig lambda chain V region 4A Ig kappa chain V-III region POM Ig kappa chain V-I region HK101 IGLV3-22(1-?) IGLV2-23(1-?) Ig lambda chain V-I region HA MYO5A Ig heavy chain V-III region WEA RAC1 ADPARPC5 WIPF3 p-5S-ABI1 IGKV1-12 ATPIGLV2-23(1-?) Ig kappa chain V-II region Cum IGLV7-43(1-?) IGLV1-36(1-?) Ig kappa chain V-I region AG Ig kappa chain V-III region POM Ig kappa chain V-III region B6 Ig heavy chain V-II region OU IGLV5-45(1-?) ARPC3 IGLV2-18(1-?) Ig kappa chain V-I region DEE IGHV7-81(1-?) Ig heavy chain V-III region WEA Ig lambda chain V-VI region AR IGHG4 Ig kappa chain V-I region DEE Ig lambda chain V-III region LOI Ig lambda chain V-I region NEWM IGLV3-25(1-?) IGLV3-27(1-?) NCKAP1 Lma amastigote surface CYFIP2 IGLV2-11(1-?) IGLV(23-?) IGLV3-27(1-?) Ig lambda chain V-II region MGC IGKC IGLV4-60(1-?) IGLV7-46(1-?) PI(3,4,5)P3 Ig kappa chain V-II region RPMI 6410 IGLC1 Ig heavy chain V-III region CAM IGLV3-12(1-?) Ig heavy chain V-II region ARH-77 IGLV11-55(1-?) IGHG3 Ig kappa chain V-I region Daudi IGKV4-1(21-?) p-6Y-SYK Ig heavy chain V-III region TRO IGKC Ig kappa chain V-I region AG IGLV3-16(1-?) Ig kappa chain V-I region AU IGHG2 Ig lambda chain V-I region VOR VAV2 ACTB(1-375) Ig kappa chain V-I region Wes Ig heavy chain V-II region WAH IGLC7 LPG1G2 NCK1 IGLV5-37(1-?) Ig lambda chain V-II region TOG p-6Y-CD247 IGHG2 Ig kappa chain V-I region AG Ig lambda chain V-I region VOR ATP IgG:Lmaantigens:FCGR3A:p-CD3 dimers:SYKIGHV7-81(1-?) IGLV4-69(1-?) RAC1 CDC42:GTP:p-Y-WASP/p-Y-WASL:WIP:SH3 proteinsIGKV1-5(23-?) RAC1:GTPIGHV7-81(1-?) Ig heavy chain V-II region OU Ig lambda chain V-IV region Hil Ig kappa chain V-I region AG PI(4,5)P2 BRK1 p-Y151,S,T-WASF1 PI(4,5)P2 IGLV7-46(1-?) IgH heavy chain V-III region VH26 precursor Ig heavy chain V-III region BRO Ig heavy chain V-II region NEWM CDC42:GDPIg lambda chain V-II region TOG IGLV1-40(1-?) Ig lambda chain V-I region NEWM GRB2-1 Lma amastigote surface ACTR3 GTP IGHG4 SYKIGLC7 p-Y160,Y171-CD3G GTPWRC:IRSp53/58:RAC1:GTP:PIP3LPG1G2 Ig kappa chain V-I region BAN IGHG2 NCKAP1L Ig lambda chain V-II region NEI Ig lambda chain V-I region HA IGHV1-2 GTP IGLV1-44(1-?) Ig heavy chain V-II region ARH-77 Ig kappa chain V-III region VG Ig heavy chain V-III region WEA Ig kappa chain V-I region HK101 IGLV4-60(1-?) IGKVA18(21-?) Ig heavy chain V-III region DOB Ig lambda chain V-I region HA Ig kappa chain V-II region FR IGLV2-18(1-?) Ig lambda chain V-IV region Hil Ig heavy chain V-I region HG3 IGLV5-45(1-?) IGLV1-40(1-?) Ig heavy chain V-III region KOL Ig heavy chain V-II region OU IGKV1-5(23-?) Ig kappa chain V-III region VG IGKV1-12 ARPC2 IGLV4-3(1-?) Ig heavy chain V-II region MCE IGLV4-60(1-?) IGLV11-55(1-?) IgH heavy chain V-III region VH26 precursor RAC1:GDPIg lambda chain V-III region LOI IGHV1-2 NCKIPSD ABI2 Ig lambda chain V-I region NEW IGLV4-3(1-?) Ig lambda chain V-III region SH Ig heavy chain V-II region OU p-Y-WRC:IRSp53/58:RAC1:GTP:PIP3IGKV2-28 Ig heavy chain V-II region MCE p-Y151-WASF3 Ig kappa chain V-II region RPMI 6410 GRB2-1 Ig kappa chain V-III region VG IGHG4 Ig kappa chain V-I region BAN Ig heavy chain V-III region DOB Ig kappa chain V-I region DEE PI(3,4,5)P3 GDPIg lambda chain V-III region SH IGLV3-25(1-?) Ig lambda chain V-I region NEW IGKC Ig heavy chain V-I region HG3 IGKV1-5(23-?) IGLV10-54(1-?) IGLV3-12(1-?) ABI2 ADPIGHV(1-?) Motherfilament:branchingcomplexIGLV(23-?) Ig kappa chain V-I region DEE ARPC5 IGLV2-11(1-?) IGKVA18(21-?) ARPC2 IGLV4-60(1-?) NCKIPSD IGHG2 F-actin IGLV3-16(1-?) IGHG4 Ig lambda chain V-II region NEI IGLC3 BRK1 Ig kappa chain V-I region AU Ig heavy chain V-II region WAH ARPC5 RAC1:GDPIg heavy chain V-II region MCE CDC42:GTP:WASP/N-WASP:WIP:SH3 proteinsIg lambda chain V-I region NEW IGLV4-3(1-?) IGKC p-5S-ABI1 Ig heavy chain V-I region EU ATPIg kappa chain V region EV15 Ig kappa chain V-III region B6 Ig kappa chain V-III region POM IGKV2-28 IGLV1-40(1-?) IGHV7-81(1-?) p-Y150-WASF2 Ig kappa chain V-I region DEE Ig lambda chain V-IV region Kern ACTR3 LPG1G2 ARPC1B IGLV5-37(1-?) Ig kappa chain V region EV15 Ig lambda chain V-I region NEWM ARPC1A Lma amastigote surface Ig kappa chain V-I region Gal p-Y150-WASF2 IGLV3-25(1-?) Ig heavy chain V-III region BRO GTPIg heavy chain V-I region HG3 IGLV4-69(1-?) Ig lambda chain V-II region MGC Ig lambda chain V-IV region Bau Ig kappa chain V region EV15 Ig heavy chain V-III region BUT Ig lambda chain V-II region BOH IGKC IGKVA18(21-?) MYO9B IGLV2-18(1-?) Ig heavy chain V-III region WEA Ig lambda chain V-II region BOH NCKAP1 Ig heavy chain V-III region BUT NCKAP1L Ig heavy chain V-III region JON IGKC Ig lambda chain V-I region NEWM IGKV1-12 IGLC6 ELMO1 IGLV4-60(1-?) IGHG4 IGLV10-54(1-?) Ig kappa chain V-I region Wes IGLV4-3(1-?) Ig lambda chain V-II region TOG IGLV4-69(1-?) IGLV3-12(1-?) Ig lambda chain V-II region NEI p-4S-ABI2 IGKVA18(21-?) IGLV8-61(1-?) p-Y174-VAV1 IGLV(23-?) IGKV1-12 IGLV2-18(1-?) WIP family proteinsIg heavy chain V-III region BRO IGLV1-36(1-?) Ig lambda chain V-VI region AR ACTG1 Ig heavy chain V-III region KOL IGLV11-55(1-?) IgG:Leishmaniasurface:FCGR3Ap-CD3dimers:p-6Y-SYK:VAV1,2,3:PI(3,4,5)P3Ig heavy chain V-II region MCE MYO9B Ig lambda chain V-III region SH Ig lambda chain V-II region BOH p-Y151,S,T-WASF1 GRB2-1 Ig heavy chain V-I region HG3 Ig heavy chain V-II region WAH Ig lambda chain V region 4A ABI2 ATP Ig heavy chain V-I region HG3 IGKV2D-30 Ig lambda chain V-III region SH Ig lambda chain V-I region VOR IGLV2-11(1-?) Ig lambda chain V-IV region Kern BRK1 IGHG1 Ig kappa chain V-II region RPMI 6410 Ig heavy chain V-II region MCE IgG:Lmaantigens:FCGR3A:p-CD3 dimers:p-6Y-SYKBRK1 ARPC3 IGKVA18(21-?) Ig kappa chain V-II region FR Ig heavy chain V-III region KOL Ig kappa chain V-I region Daudi Myosin-X dimerIg heavy chain V-II region OU Ig kappa chain V region EV15 Ig lambda chain V-III region LOI IGLV7-46(1-?) NCKAP1 Ig heavy chain V-II region OU CYFIP1 IGLV3-16(1-?) Ig heavy chain V-III region BUT LYN Ig heavy chain V-I region EU Ig lambda chain V-I region VOR Ig lambda chain V-I region HA Ig heavy chain V-I region HG3 IGLV4-3(1-?) IGLV3-22(1-?) IGLC3 Ig lambda chain V-I region NEW Ig lambda chain V-II region NEI CYFIP2 p-Y151,S,T-WASF3 Ig heavy chain V-I region EU Ig lambda chain V-II region NEI Ig kappa chain V-II region RPMI 6410 IGLC7 Ig kappa chain V-I region Wes Ig heavy chain V-III region KOL Ig heavy chain V-II region MCE p-Y160,Y171-CD3G Ig lambda chain V-II region NEI IGLV5-45(1-?) IGLV2-11(1-?) Src-kinasesIGLV3-27(1-?) MYO10 Ig lambda chain V-II region BOH NCKIPSD Ig kappa chain V region EV15 NCKAP1 Ig lambda chain V-I region VOR ATPIg heavy chain V-II region NEWM IGLV3-25(1-?) CYFIP1 Ig heavy chain V-I region EU Ig heavy chain V-II region ARH-77 Ig kappa chain V-III region B6 IGKV1-12 IGLV7-46(1-?) Actin filament boundMyosin-XABI1 ABL1p-T185,Y187-MAPK1 Ig lambda chain V-II region MGC VAV1 BAIAP2 FYN PI(3,4,5)P3 PI(3,4)P2Ig heavy chain V-II region ARH-77 IGLV2-18(1-?) ARPC5 IGLV3-22(1-?) IGLV3-22(1-?) IGLV3-25(1-?) IGLC2 Ig heavy chain V-II region MCE IGLV2-23(1-?) IGKV2D-30 Ig lambda chain V-II region TOG Ig heavy chain V-III region BUT Ig kappa chain V-II region RPMI 6410 Ig lambda chain V-II region NEI LPG1G2 IGHV1-2 ATPIg heavy chain V-II region NEWM DOCK1 Ig heavy chain V-II region ARH-77 GTP Ig heavy chain V-III region CAM IgG:Leishmaniasurface:p-FCGR3A:p-6Y-SYK:p-VAV1,2,3:PI(3,4,5)P3Ig lambda chain V-III region SH IGLV4-60(1-?) Ig kappa chain V-I region HK101 Ig lambda chain V-IV region Hil IGLC3 Ig lambda chain V-I region NEWM Ig kappa chain V-I region Daudi CDC42 Ig kappa chain V-I region AG ARPC5 Ig kappa chain V-II region FR IgG:Lma antigensIGLV2-33(1-?) MYH9 Ig kappa chain V-I region HK101 GDPp-5S-ABI1 IGLV8-61(1-?) N-WASP IGLV11-55(1-?) IGKV2-28 Ig heavy chain V-III region BRO WASF1 Ig lambda chain V-IV region Hil IGHV1-2 Ig kappa chain V-I region AG IGHG3 HCK IGKV2D-30 Ig kappa chain V-III region POM Ig lambda chain V-II region BOH IGKC Ig heavy chain V-III region BRO IGKV2D-30 IGLV1-36(1-?) IGLV1-44(1-?) Ig lambda chain V-IV region Kern N-WASP ARPC1A IGLC1 WAS IGLV7-46(1-?) NCK1 IGLV(23-?) IGLV3-12(1-?) IGLV2-33(1-?) Ig lambda chain V-II region BOH p-Y160,Y171-CD3G Ig kappa chain V-I region DEE IGLV4-69(1-?) Ig kappa chain V-I region AU IGKV3D-20 Ig kappa chain V-I region Daudi IGLV3-16(1-?) Ig kappa chain V-I region Gal Ig heavy chain V-III region DOB IGLV8-61(1-?) NCKAP1 Ig lambda chain V-I region NEW GTP IGHV(1-?) IGLC7 Ig heavy chain V-I region HG3 WAS Ig kappa chain V-I region Daudi Ig lambda chain V-I region VOR IGHG2 ATP IGLV3-16(1-?) CDC42 VAV1,2,3Ig heavy chain V-III region TRO YES1 Ig lambda chain V-IV region Bau IgH heavy chain V-III region VH26 precursor Ig heavy chain V-II region NEWM LPG1G2 IGLV2-33(1-?) IGKC Ig kappa chain V-I region BAN IGLV3-25(1-?) IGLV8-61(1-?) p-Y160,Y171-CD3G Src family kinases(SFKs)GRB2-1 Ig kappa chain V-III region VG Ig heavy chain V-III region TRO CDC42 IGLV10-54(1-?) IGLV4-3(1-?) ARPC4 Ig kappa chain V-I region Daudi Ig lambda chain V-I region NEW Ig heavy chain V-II region NEWM IGKV1-5(23-?) WIPF1 N-WASP IGLV10-54(1-?) p-4S-ABI2 Ig kappa chain V-II region Cum ARPC3 WIPF3 ELMO1 IGLV8-61(1-?) p-Y173-VAV3 Ig kappa chain V-III region POM IGHG1 IGLV5-45(1-?) IGLV4-3(1-?) RAC1 IGLV3-16(1-?) Ig lambda chain V-IV region Bau CRK NCKAP1 Ig heavy chain V-III region BRO ADPIg kappa chain V region EV15 IGKV1-5(23-?) p-Y151-WASF1 CYFIP2 IGLC2 Ig heavy chain V-III region BRO IGLV5-45(1-?) Ig lambda chain V-IV region Bau IgH heavy chain V-III region VH26 precursor GTP IgG:Leishmaniasurface:FCGR3AIg kappa chain V-II region FR IGLC7 Ig kappa chain V-I region Gal IGLV1-44(1-?) IGLV2-11(1-?) ABI2 IGLV7-43(1-?) IGLV10-54(1-?) GRB2-1 CD3G NCKIPSD IGLC6 IGLV4-69(1-?) Ig heavy chain V-II region MCE Ig lambda chain V-III region LOI IGLV2-23(1-?) PI(3,4,5)P3 Ig lambda chain V-VI region AR IGLV7-46(1-?) IGHV1-2 IGHG3 Ig heavy chain V-III region WEA ACTR3 IGKV2-28 Ig kappa chain V-II region RPMI 6410 IGKV4-1(21-?) IGLV3-27(1-?) p-6Y-CD247 Ig heavy chain V-II region WAH IGKV2-28 Ig kappa chain V-III region B6 BRK1 p-Y151,S,T-WASF3 Ig heavy chain V-III region JON p-Y291-WAS Ig heavy chain V-III region JON Ig heavy chain V-II region ARH-77 IGKV2D-30 Ig lambda chain V-I region NEW IGKC IGKV1-12 Ig lambda chain V-IV region Bau ADP Ig heavy chain V-I region EU G-actinWASF2 ACTR2 FGR ATPWIPF3 IGLC6 Ig heavy chain V-II region WAH Ig lambda chain V-II region NEI SRC-1 CD247-1 WIPF2 IGLV1-40(1-?) IGLC7 LPG1G2 IGLV3-12(1-?) Ig lambda chain V-IV region Kern Ig lambda chain V-I region HA WIPF3 Myosin-ActinfilamentsIg kappa chain V-II region RPMI 6410 p-6Y-SYK IGLC6 GRB2-1 Ig lambda chain V-II region BOH Ig lambda chain V-VI region AR Ig lambda chain V-IV region Bau LYN IGKV2D-30 IGLV3-22(1-?) p-Y151-WASF1 IGLV1-36(1-?) IGLV2-33(1-?) IGLV8-61(1-?) WASP/N-WASPIg lambda chain V-VI region AR Ig heavy chain V-III region DOB IGKV1-12 Lma amastigote surface IgG:Leishmaniasurface:p-FCGR3A:p-6Y-SYK:CRKII:DOCK180:ELMOIg kappa chain V-I region HK101 Ig heavy chain V-III region WEA CYFIP1 Ig lambda chain V-II region BOH Ig lambda chain V-II region TOG IGLV7-43(1-?) IGLV3-16(1-?) GTP ADP MYH9 IGLV1-36(1-?) Ig heavy chain V-III region DOB Ig lambda chain V-IV region Hil BRK1 Ig lambda chain V-I region NEW NCK1 IGLV1-36(1-?) Ig lambda chain V-II region BOH Ig heavy chain V-II region ARH-77 IGKV1-5(23-?) Ig lambda chain V-VI region AR IGLV7-46(1-?) p-4S-ABI2 IGKV1-12 IGLC2 Ig heavy chain V-II region NEWM Ig kappa chain V-II region Cum p-6Y-SYK ACTR3 Ig kappa chain V-I region DEE IGLV2-33(1-?) Ig heavy chain V-III region TRO IGLV4-60(1-?) N-WASP Ig lambda chain V-III region LOI IGHV(1-?) ARPC4 IGLC6 IGLV11-55(1-?) Ig kappa chain V-I region AU IGKV4-1(21-?) IGKVA18(21-?) IGLV1-44(1-?) IGLV1-44(1-?) IGLV3-25(1-?) Ig heavy chain V-III region CAM IGHV(1-?) IGLV2-23(1-?) Ig heavy chain V-III region BUT IGHG1 IGLC1 IGLV1-40(1-?) IgH heavy chain V-III region VH26 precursor Ig heavy chain V-III region CAM Ig kappa chain V-I region Gal IGLV4-3(1-?) Ig lambda chain V-II region NEI IGLC6 IgG:Lmaantigens:FCGR3A:p-CD3 dimersIGLV1-40(1-?) IGLV2-33(1-?) IGKV3D-20 ACTR3 Ig kappa chain V-III region POM Ig lambda chain V-III region SH ARPC2 Ig kappa chain V-II region FR Ig lambda chain V-II region MGC Src family kinases(SFKs)p-Y256-WASL Ig heavy chain V-III region WEA Ig kappa chain V-II region RPMI 6410 Ig heavy chain V-III region KOL Ig heavy chain V-I region EU ABI1 HCK p-Y256-WASL IGLV(23-?) IGLC7 IgG:Lma amastigotesurfaceIGKV4-1(21-?) Ig heavy chain V-I region EU Ig lambda chain V-II region MGC IGKC GTP Ig kappa chain V-II region FR Ig heavy chain V-I region EU Ig kappa chain V-I region DEE IGLC3 IGLC1 ACTB(1-375) IgG:LPG1G2IGLV4-60(1-?) Ig heavy chain V-I region HG3 p-Y150,S343,T346-WASF2 Ig heavy chain V-III region BRO p-6Y-CD247 ARPC2 DOCK1 Ig lambda chain V-III region SH IGLC7 IGKV2D-30 IGHV7-81(1-?) IGLV4-3(1-?) p-5S-ABI1 Ig kappa chain V-III region VG Ig kappa chain V-II region Cum Ig kappa chain V-II region Cum Ig heavy chain V-III region DOB Ig lambda chain V-I region NEWM Ig heavy chain V-III region TRO Motherfilament:ARP2/3:actin:ADPIg heavy chain V-III region DOB WIPF1 Ig kappa chain V-I region Daudi IGHG3 ARPC4 Ig lambda chain V-I region NEWM IGLV5-37(1-?) Ig kappa chain V-III region POM IGLV1-36(1-?) CYFIP1 ARPC3 IGLV11-55(1-?) CYFIP2 Ig lambda chain V-II region TOG ARPC4 IGHG4 Ig lambda chain V-I region HA IGLV3-16(1-?) IGLV4-69(1-?) Ig lambda chain V-I region NEWM Ig lambda chain V-I region NEW IGLC1 CD3G IGLV3-27(1-?) Ig lambda chain V-I region NEWM WASF2 PI(3,4,5)P3 IGKC IGLV7-43(1-?) CYFIP1 Ig lambda chain V-III region SH Ig kappa chain V-I region Wes p-Y256-WASL IGLV10-54(1-?) Lma amastigote surface IGKV3D-20 Ig kappa chain V region EV15 IGHV1-2 IGLC1 IGLV5-37(1-?) Ig heavy chain V-III region BUT Ig lambda chain V-IV region Bau Ig heavy chain V-III region TRO Ig kappa chain V-II region Cum YES1 IGLV3-27(1-?) IGLV3-12(1-?) Ig heavy chain V-III region WEA ARPC2 Ig heavy chain V-III region KOL IGHG3 Lma amastigotesurfaceIGLC3 BAIAP2 ELMO2 IGLV2-23(1-?) Ig heavy chain V-III region DOB Ig heavy chain V-III region KOL IGHG3 Ig heavy chain V-III region BRO Ig lambda chain V-II region MGC Ig heavy chain V-III region TRO NCKAP1L IGLV7-43(1-?) PIP3:VAV1,2,3ATP IgH heavy chain V-III region VH26 precursor Ig lambda chain V-II region MGC FCGR3A ADPIGLC2 ARPC4 Ig lambda chain V-III region LOI IgH heavy chain V-III region VH26 precursor IGLV5-37(1-?) Ig heavy chain V-I region HG3 IGKV2D-30 IGHV1-2 IGLV3-22(1-?) Ig lambda chain V-I region NEWM IGLC7 IGLV10-54(1-?) IGLV7-46(1-?) Ig lambda chain V-I region NEW Ig kappa chain V-III region B6 IGLV11-55(1-?) Ig lambda chain V-IV region Bau IGKV1-12 Ig lambda chain V-III region LOI IGKV3D-20 Ig kappa chain V-III region VG Ig lambda chain V-II region MGC ARPC1A Ig lambda chain V-III region SH ARPC4 IGLC3 IGKV2D-30 FCGR3A Ig heavy chain V-III region BRO IGKV3D-20 Ig kappa chain V-I region BAN IGLV2-23(1-?) Ig kappa chain V-I region AG IGLV5-37(1-?) IGLC1 Ig kappa chain V-I region AU Ig kappa chain V-I region AU GDP VAV2 Ig lambda chain V region 4A Ig kappa chain V-III region POM ARPC1B Ig lambda chain V-I region HA Ig kappa chain V-I region AU Ig lambda chain V-II region MGC ABI1 WIPF2 Ig lambda chain V-III region SH


Description

The Fc gamma receptors (FCGRs) have been reported to facilitate Leishmania internalization, especially when in its amastigote form (Ueno et al. 2012). Following cell-to-cell propagation within an established infection or reinfection of a previously infected host, the IgG produced by the host covers the surface of Leishmania amastigote parasites, making them more susceptible to phagocytosis through FCGRs (Polando et al. 2013).

Classically, phagocytosis via FCGRs has been associated with the subsequent activation of Rac GTPases and Cdc42 which in turn activate the phagocyte's NADPH oxidase, contributing to the activation of killing mechanisms (Ueno et al. 2012). View original pathway at Reactome.

Comments

Reactome-Converter 
Pathway is converted from Reactome ID: 9664422
Reactome-version 
Reactome version: 75
Reactome Author 
Reactome Author: Jassal, Bijay

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Suzuki T, Kono H, Hirose N, Okada M, Yamamoto T, Yamamoto K, Honda Z.; ''Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis.''; PubMed Europe PMC Scholia
  2. Durden DL, Liu YB.; ''Protein-tyrosine kinase p72syk in Fc gamma RI receptor signaling.''; PubMed Europe PMC Scholia
  3. Nakanishi O, Suetsugu S, Yamazaki D, Takenawa T.; ''Effect of WAVE2 phosphorylation on activation of the Arp2/3 complex.''; PubMed Europe PMC Scholia
  4. Park H, Cox D.; ''Cdc42 regulates Fc gamma receptor-mediated phagocytosis through the activation and phosphorylation of Wiskott-Aldrich syndrome protein (WASP) and neural-WASP.''; PubMed Europe PMC Scholia
  5. El-Hillal O, Kurosaki T, Yamamura H, Kinet JP, Scharenberg AM.; ''syk kinase activation by a src kinase-initiated activation loop phosphorylation chain reaction.''; PubMed Europe PMC Scholia
  6. Ueno N, Wilson ME.; ''Receptor-mediated phagocytosis of Leishmania: implications for intracellular survival.''; PubMed Europe PMC Scholia
  7. Xu X, Chong AS.; ''Vav in natural killer cells is tyrosine phosphorylated upon cross-linking of Fc gamma RIIIA and is constitutively associated with a serine/threonine kinase.''; PubMed Europe PMC Scholia
  8. Massol P, Montcourrier P, Guillemot JC, Chavrier P.; ''Fc receptor-mediated phagocytosis requires CDC42 and Rac1.''; PubMed Europe PMC Scholia
  9. Le Clainche C, Carlier MF.; ''Regulation of actin assembly associated with protrusion and adhesion in cell migration.''; PubMed Europe PMC Scholia
  10. Kato M, Miki H, Kurita S, Endo T, Nakagawa H, Miyamoto S, Takenawa T.; ''WICH, a novel verprolin homology domain-containing protein that functions cooperatively with N-WASP in actin-microspike formation.''; PubMed Europe PMC Scholia
  11. Ho HY, Rohatgi R, Ma L, Kirschner MW.; ''CR16 forms a complex with N-WASP in brain and is a novel member of a conserved proline-rich actin-binding protein family.''; PubMed Europe PMC Scholia
  12. Kiener PA, Rankin BM, Burkhardt AL, Schieven GL, Gilliland LK, Rowley RB, Bolen JB, Ledbetter JA.; ''Cross-linking of Fc gamma receptor I (Fc gamma RI) and receptor II (Fc gamma RII) on monocytic cells activates a signal transduction pathway common to both Fc receptors that involves the stimulation of p72 Syk protein tyrosine kinase.''; PubMed Europe PMC Scholia
  13. Crowley MT, Costello PS, Fitzer-Attas CJ, Turner M, Meng F, Lowell C, Tybulewicz VL, DeFranco AL.; ''A critical role for Syk in signal transduction and phagocytosis mediated by Fcgamma receptors on macrophages.''; PubMed Europe PMC Scholia
  14. Zhang J, Berenstein E, Siraganian RP.; ''Phosphorylation of Tyr342 in the linker region of Syk is critical for Fc epsilon RI signaling in mast cells.''; PubMed Europe PMC Scholia
  15. Lupher ML, Rao N, Lill NL, Andoniou CE, Miyake S, Clark EA, Druker B, Band H.; ''Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323.''; PubMed Europe PMC Scholia
  16. Tsang E, Giannetti AM, Shaw D, Dinh M, Tse JK, Gandhi S, Ho H, Wang S, Papp E, Bradshaw JM.; ''Molecular mechanism of the Syk activation switch.''; PubMed Europe PMC Scholia
  17. Egile C, Rouiller I, Xu XP, Volkmann N, Li R, Hanein D.; ''Mechanism of filament nucleation and branch stability revealed by the structure of the Arp2/3 complex at actin branch junctions.''; PubMed Europe PMC Scholia
  18. Padigel UM, Farrell JP.; ''Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.''; PubMed Europe PMC Scholia
  19. Zalevsky J, Lempert L, Kranitz H, Mullins RD.; ''Different WASP family proteins stimulate different Arp2/3 complex-dependent actin-nucleating activities.''; PubMed Europe PMC Scholia
  20. Mendoza MC, Er EE, Zhang W, Ballif BA, Elliott HL, Danuser G, Blenis J.; ''ERK-MAPK drives lamellipodia protrusion by activating the WAVE2 regulatory complex.''; PubMed Europe PMC Scholia
  21. Swanson JA, Johnson MT, Beningo K, Post P, Mooseker M, Araki N.; ''A contractile activity that closes phagosomes in macrophages.''; PubMed Europe PMC Scholia
  22. Han J, Luby-Phelps K, Das B, Shu X, Xia Y, Mosteller RD, Krishna UM, Falck JR, White MA, Broek D.; ''Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav.''; PubMed Europe PMC Scholia
  23. Rohatgi R, Nollau P, Ho HY, Kirschner MW, Mayer BJ.; ''Nck and phosphatidylinositol 4,5-bisphosphate synergistically activate actin polymerization through the N-WASP-Arp2/3 pathway.''; PubMed Europe PMC Scholia
  24. Chavrier P.; ''May the force be with you: Myosin-X in phagocytosis.''; PubMed Europe PMC Scholia
  25. Deckert M, Tartare-Deckert S, Couture C, Mustelin T, Altman A.; ''Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product.''; PubMed Europe PMC Scholia
  26. Chu N, Thomas BN, Patel SR, Buxbaum LU.; ''IgG1 is pathogenic in Leishmania mexicana infection.''; PubMed Europe PMC Scholia
  27. Kim AS, Kakalis LT, Abdul-Manan N, Liu GA, Rosen MK.; ''Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein.''; PubMed Europe PMC Scholia
  28. Cox D, Berg JS, Cammer M, Chinegwundoh JO, Dale BM, Cheney RE, Greenberg S.; ''Myosin X is a downstream effector of PI(3)K during phagocytosis.''; PubMed Europe PMC Scholia
  29. Aspenström P.; ''The WASP-binding protein WIRE has a role in the regulation of the actin filament system downstream of the platelet-derived growth factor receptor.''; PubMed Europe PMC Scholia
  30. Edberg JC, Redecha PB, Salmon JE, Kimberly RP.; ''Human Fc gamma RIII (CD16). Isoforms with distinct allelic expression, extracellular domains, and membrane linkages on polymorphonuclear and natural killer cells.''; PubMed Europe PMC Scholia
  31. Hall AB, Gakidis MA, Glogauer M, Wilsbacher JL, Gao S, Swat W, Brugge JS.; ''Requirements for Vav guanine nucleotide exchange factors and Rho GTPases in FcgammaR- and complement-mediated phagocytosis.''; PubMed Europe PMC Scholia
  32. Cory GO, Garg R, Cramer R, Ridley AJ.; ''Phosphorylation of tyrosine 291 enhances the ability of WASp to stimulate actin polymerization and filopodium formation. Wiskott-Aldrich Syndrome protein.''; PubMed Europe PMC Scholia
  33. Wirthmueller U, Kurosaki T, Murakami MS, Ravetch JV.; ''Signal transduction by Fc gamma RIII (CD16) is mediated through the gamma chain.''; PubMed Europe PMC Scholia
  34. Kovar DR.; ''Arp2/3 ATP hydrolysis: to branch or to debranch?''; PubMed Europe PMC Scholia
  35. Fukuoka M, Suetsugu S, Miki H, Fukami K, Endo T, Takenawa T.; ''A novel neural Wiskott-Aldrich syndrome protein (N-WASP) binding protein, WISH, induces Arp2/3 complex activation independent of Cdc42.''; PubMed Europe PMC Scholia
  36. Diakonova M, Bokoch G, Swanson JA.; ''Dynamics of cytoskeletal proteins during Fcgamma receptor-mediated phagocytosis in macrophages.''; PubMed Europe PMC Scholia
  37. Agarwal A, Salem P, Robbins KC.; ''Involvement of p72syk, a protein-tyrosine kinase, in Fc gamma receptor signaling.''; PubMed Europe PMC Scholia
  38. Mullins RD, Heuser JA, Pollard TD.; ''The interaction of Arp2/3 complex with actin: nucleation, high affinity pointed end capping, and formation of branching networks of filaments.''; PubMed Europe PMC Scholia
  39. Beemiller P, Zhang Y, Mohan S, Levinsohn E, Gaeta I, Hoppe AD, Swanson JA.; ''A Cdc42 activation cycle coordinated by PI 3-kinase during Fc receptor-mediated phagocytosis.''; PubMed Europe PMC Scholia
  40. Morehead J, Coppens I, Andrews NW.; ''Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.''; PubMed Europe PMC Scholia
  41. Lee WL, Cosio G, Ireton K, Grinstein S.; ''Role of CrkII in Fcgamma receptor-mediated phagocytosis.''; PubMed Europe PMC Scholia
  42. Strzelecka A, Kwiatkowska K, Sobota A.; ''Tyrosine phosphorylation and Fcgamma receptor-mediated phagocytosis.''; PubMed Europe PMC Scholia
  43. Furlong MT, Mahrenholz AM, Kim KH, Ashendel CL, Harrison ML, Geahlen RL.; ''Identification of the major sites of autophosphorylation of the murine protein-tyrosine kinase Syk.''; PubMed Europe PMC Scholia
  44. Ghazizadeh S, Bolen JB, Fleit HB.; ''Tyrosine phosphorylation and association of Syk with Fc gamma RII in monocytic THP-1 cells.''; PubMed Europe PMC Scholia
  45. Takenawa T, Miki H.; ''WASP and WAVE family proteins: key molecules for rapid rearrangement of cortical actin filaments and cell movement.''; PubMed Europe PMC Scholia
  46. Huang ZY, Barreda DR, Worth RG, Indik ZK, Kim MK, Chien P, Schreiber AD.; ''Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis.''; PubMed Europe PMC Scholia
  47. Carlier MF, Nioche P, Broutin-L'Hermite I, Boujemaa R, Le Clainche C, Egile C, Garbay C, Ducruix A, Sansonetti P, Pantaloni D.; ''GRB2 links signaling to actin assembly by enhancing interaction of neural Wiskott-Aldrich syndrome protein (N-WASp) with actin-related protein (ARP2/3) complex.''; PubMed Europe PMC Scholia
  48. Suetsugu S, Kurisu S, Oikawa T, Yamazaki D, Oda A, Takenawa T.; ''Optimization of WAVE2 complex-induced actin polymerization by membrane-bound IRSp53, PIP(3), and Rac.''; PubMed Europe PMC Scholia
  49. Moreau V, Frischknecht F, Reckmann I, Vincentelli R, Rabut G, Stewart D, Way M.; ''A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization.''; PubMed Europe PMC Scholia
  50. Callebaut I, Cossart P, Dehoux P.; ''EVH1/WH1 domains of VASP and WASP proteins belong to a large family including Ran-binding domains of the RanBP1 family.''; PubMed Europe PMC Scholia
  51. Buxbaum LU.; ''Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.''; PubMed Europe PMC Scholia
  52. Matsuda M, Park JG, Wang DC, Hunter S, Chien P, Schreiber AD.; ''Abrogation of the Fc gamma receptor IIA-mediated phagocytic signal by stem-loop Syk antisense oligonucleotides.''; PubMed Europe PMC Scholia
  53. Rohatgi R, Ma L, Miki H, Lopez M, Kirchhausen T, Takenawa T, Kirschner MW.; ''The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly.''; PubMed Europe PMC Scholia
  54. Leng Y, Zhang J, Badour K, Arpaia E, Freeman S, Cheung P, Siu M, Siminovitch K.; ''Abelson-interactor-1 promotes WAVE2 membrane translocation and Abelson-mediated tyrosine phosphorylation required for WAVE2 activation.''; PubMed Europe PMC Scholia
  55. Amann KJ, Pollard TD.; ''The Arp2/3 complex nucleates actin filament branches from the sides of pre-existing filaments.''; PubMed Europe PMC Scholia
  56. Huang MM, Indik Z, Brass LF, Hoxie JA, Schreiber AD, Brugge JS.; ''Activation of Fc gamma RII induces tyrosine phosphorylation of multiple proteins including Fc gamma RII.''; PubMed Europe PMC Scholia
  57. Higgs HN, Pollard TD.; ''Activation by Cdc42 and PIP(2) of Wiskott-Aldrich syndrome protein (WASp) stimulates actin nucleation by Arp2/3 complex.''; PubMed Europe PMC Scholia
  58. Millard TH, Sharp SJ, Machesky LM.; ''Signalling to actin assembly via the WASP (Wiskott-Aldrich syndrome protein)-family proteins and the Arp2/3 complex.''; PubMed Europe PMC Scholia
  59. Thomas BN, Buxbaum LU.; ''FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.''; PubMed Europe PMC Scholia
  60. Polando R, Dixit UG, Carter CR, Jones B, Whitcomb JP, Ballhorn W, Harintho M, Jerde CL, Wilson ME, McDowell MA.; ''The roles of complement receptor 3 and Fcγ receptors during Leishmania phagosome maturation.''; PubMed Europe PMC Scholia
  61. Bompard G, Caron E.; ''Regulation of WASP/WAVE proteins: making a long story short.''; PubMed Europe PMC Scholia
  62. Wu X, Suetsugu S, Cooper LA, Takenawa T, Guan JL.; ''Focal adhesion kinase regulation of N-WASP subcellular localization and function.''; PubMed Europe PMC Scholia
  63. Miki H, Suetsugu S, Takenawa T.; ''WAVE, a novel WASP-family protein involved in actin reorganization induced by Rac.''; PubMed Europe PMC Scholia
  64. Le Clainche C, Pantaloni D, Carlier MF.; ''ATP hydrolysis on actin-related protein 2/3 complex causes debranching of dendritic actin arrays.''; PubMed Europe PMC Scholia

History

CompareRevisionActionTimeUserComment
114922view16:44, 25 January 2021ReactomeTeamReactome version 75
113367view11:44, 2 November 2020ReactomeTeamReactome version 74
112818view18:23, 9 October 2020DeSlOntology Term : 'phagocytosis pathway' added !
112766view16:16, 9 October 2020ReactomeTeamNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
ABI1 ProteinQ8IZP0 (Uniprot-TrEMBL)
ABI2 ProteinQ9NYB9 (Uniprot-TrEMBL)
ABL1ProteinP00519 (Uniprot-TrEMBL)
ACTB(1-375) ProteinP60709 (Uniprot-TrEMBL)
ACTG1 ProteinP63261 (Uniprot-TrEMBL)
ACTR2 ProteinP61160 (Uniprot-TrEMBL)
ACTR3 ProteinP61158 (Uniprot-TrEMBL)
ADP MetaboliteCHEBI:456216 (ChEBI)
ADPMetaboliteCHEBI:456216 (ChEBI)
ARP2/3 complex (ATP bound)ComplexR-HSA-1861670 (Reactome)
ARPC1A ProteinQ92747 (Uniprot-TrEMBL)
ARPC1B ProteinO15143 (Uniprot-TrEMBL)
ARPC2 ProteinO15144 (Uniprot-TrEMBL)
ARPC3 ProteinO15145 (Uniprot-TrEMBL)
ARPC4 ProteinP59998 (Uniprot-TrEMBL)
ARPC5 ProteinO15511 (Uniprot-TrEMBL)
ATP MetaboliteCHEBI:30616 (ChEBI)
ATPMetaboliteCHEBI:30616 (ChEBI)
Actin filament bound Myosin-XComplexR-HSA-1861625 (Reactome)
BAIAP2 ProteinQ9UQB8 (Uniprot-TrEMBL)
BAIAP2ProteinQ9UQB8 (Uniprot-TrEMBL)
BRK1 ProteinQ8WUW1 (Uniprot-TrEMBL)
BTK ProteinQ06187 (Uniprot-TrEMBL)
CD247-1 ProteinP20963-1 (Uniprot-TrEMBL)
CD3G ProteinP09693 (Uniprot-TrEMBL)
CDC42 ProteinP60953 (Uniprot-TrEMBL)
CDC42:GDPComplexR-HSA-418830 (Reactome)
CDC42:GTP:WASP/N-WASP:WIP:SH3 proteinsComplexR-HSA-2197683 (Reactome)
CDC42:GTP:WASP/N-WASPComplexR-HSA-442584 (Reactome)
CDC42:GTP:p-Y-WASP/p-Y-WASL:WIP:SH3 proteinsComplexR-HSA-2197680 (Reactome)
CDC42:GTPComplexR-HSA-182921 (Reactome)
CRK ProteinP46108 (Uniprot-TrEMBL)
CRK:DOCK180:ELMO1,ELMO2ComplexR-HSA-2029141 (Reactome)
CYFIP1 ProteinQ7L576 (Uniprot-TrEMBL)
CYFIP2 ProteinQ96F07 (Uniprot-TrEMBL)
DOCK1 ProteinQ14185 (Uniprot-TrEMBL)
ELMO1 ProteinQ92556 (Uniprot-TrEMBL)
ELMO2 ProteinQ96JJ3 (Uniprot-TrEMBL)
F-actin R-HSA-201877 (Reactome)
F-actinR-HSA-201877 (Reactome)
FCGR3A ProteinP08637 (Uniprot-TrEMBL)
FCGRIIIA:CD3G/CD3Z dimersComplexR-HSA-2029097 (Reactome)
FGR ProteinP09769 (Uniprot-TrEMBL)
FYN ProteinP06241 (Uniprot-TrEMBL)
G-actinComplexR-HSA-201857 (Reactome)
GDP MetaboliteCHEBI:17552 (ChEBI)
GDPMetaboliteCHEBI:17552 (ChEBI)
GRB2-1 ProteinP62993-1 (Uniprot-TrEMBL)
GTP MetaboliteCHEBI:15996 (ChEBI)
GTPMetaboliteCHEBI:15996 (ChEBI)
HCK ProteinP08631 (Uniprot-TrEMBL)
IGHG1 ProteinP01857 (Uniprot-TrEMBL)
IGHG2 ProteinP01859 (Uniprot-TrEMBL)
IGHG3 ProteinP01860 (Uniprot-TrEMBL)
IGHG4 ProteinP01861 (Uniprot-TrEMBL)
IGHV(1-?) ProteinA2KUC3 (Uniprot-TrEMBL)
IGHV1-2 ProteinP23083 (Uniprot-TrEMBL)
IGHV7-81(1-?) ProteinQ6PIL0 (Uniprot-TrEMBL)
IGKC ProteinP01834 (Uniprot-TrEMBL)
IGKV1-12 ProteinA0A0C4DH73 (Uniprot-TrEMBL)
IGKV1-5(23-?) ProteinP01602 (Uniprot-TrEMBL)
IGKV2-28 ProteinA0A075B6P5 (Uniprot-TrEMBL)
IGKV2D-30 ProteinA0A075B6S6 (Uniprot-TrEMBL)
IGKV3D-20 ProteinA0A0C4DH25 (Uniprot-TrEMBL)
IGKV4-1(21-?) ProteinP06312 (Uniprot-TrEMBL)
IGKVA18(21-?) ProteinA2NJV5 (Uniprot-TrEMBL)
IGLC1 ProteinP0CG04 (Uniprot-TrEMBL)
IGLC2 ProteinP0DOY2 (Uniprot-TrEMBL)
IGLC3 ProteinP0DOY3 (Uniprot-TrEMBL)
IGLC6 ProteinP0CF74 (Uniprot-TrEMBL)
IGLC7 ProteinA0M8Q6 (Uniprot-TrEMBL)
IGLV(23-?) ProteinA2NXD2 (Uniprot-TrEMBL)
IGLV1-36(1-?) ProteinQ5NV67 (Uniprot-TrEMBL)
IGLV1-40(1-?) ProteinQ5NV69 (Uniprot-TrEMBL)
IGLV1-44(1-?) ProteinQ5NV81 (Uniprot-TrEMBL)
IGLV10-54(1-?) ProteinQ5NV86 (Uniprot-TrEMBL)
IGLV11-55(1-?) ProteinQ5NV87 (Uniprot-TrEMBL)
IGLV2-11(1-?) ProteinQ5NV84 (Uniprot-TrEMBL)
IGLV2-18(1-?) ProteinQ5NV65 (Uniprot-TrEMBL)
IGLV2-23(1-?) ProteinQ5NV89 (Uniprot-TrEMBL)
IGLV2-33(1-?) ProteinQ5NV66 (Uniprot-TrEMBL)
IGLV3-12(1-?) ProteinQ5NV85 (Uniprot-TrEMBL)
IGLV3-16(1-?) ProteinQ5NV64 (Uniprot-TrEMBL)
IGLV3-22(1-?) ProteinQ5NV75 (Uniprot-TrEMBL)
IGLV3-25(1-?) ProteinQ5NV90 (Uniprot-TrEMBL)
IGLV3-27(1-?) ProteinQ5NV91 (Uniprot-TrEMBL)
IGLV4-3(1-?) ProteinQ5NV61 (Uniprot-TrEMBL)
IGLV4-60(1-?) ProteinQ5NV79 (Uniprot-TrEMBL)
IGLV4-69(1-?) ProteinQ5NV92 (Uniprot-TrEMBL)
IGLV5-37(1-?) ProteinQ5NV68 (Uniprot-TrEMBL)
IGLV5-45(1-?) ProteinQ5NV82 (Uniprot-TrEMBL)
IGLV7-43(1-?) ProteinQ5NV80 (Uniprot-TrEMBL)
IGLV7-46(1-?) ProteinQ5NV83 (Uniprot-TrEMBL)
IGLV8-61(1-?) ProteinQ5NV62 (Uniprot-TrEMBL)
Ig heavy chain V-I region EU ProteinP01742 (Uniprot-TrEMBL)
Ig heavy chain V-I region HG3 ProteinP01743 (Uniprot-TrEMBL)
Ig heavy chain V-II region ARH-77 ProteinP06331 (Uniprot-TrEMBL)
Ig heavy chain V-II region MCE ProteinP01817 (Uniprot-TrEMBL)
Ig heavy chain V-II region NEWM ProteinP01825 (Uniprot-TrEMBL)
Ig heavy chain V-II region OU ProteinP01814 (Uniprot-TrEMBL)
Ig heavy chain V-II region WAH ProteinP01824 (Uniprot-TrEMBL)
Ig heavy chain V-III region BRO ProteinP01766 (Uniprot-TrEMBL)
Ig heavy chain V-III region BUT ProteinP01767 (Uniprot-TrEMBL)
Ig heavy chain V-III region CAM ProteinP01768 (Uniprot-TrEMBL)
Ig heavy chain V-III region DOB ProteinP01782 (Uniprot-TrEMBL)
Ig heavy chain V-III region JON ProteinP01780 (Uniprot-TrEMBL)
Ig heavy chain V-III region KOL ProteinP01772 (Uniprot-TrEMBL)
Ig heavy chain V-III region TRO ProteinP01762 (Uniprot-TrEMBL)
Ig heavy chain V-III region WEA ProteinP01763 (Uniprot-TrEMBL)
Ig kappa chain V region EV15 ProteinP06315 (Uniprot-TrEMBL)
Ig kappa chain V-I region AG ProteinP01593 (Uniprot-TrEMBL)
Ig kappa chain V-I region AU ProteinP01594 (Uniprot-TrEMBL)
Ig kappa chain V-I region BAN ProteinP04430 (Uniprot-TrEMBL)
Ig kappa chain V-I region DEE ProteinP01597 (Uniprot-TrEMBL)
Ig kappa chain V-I region Daudi ProteinP04432 (Uniprot-TrEMBL)
Ig kappa chain V-I region Gal ProteinP01599 (Uniprot-TrEMBL)
Ig kappa chain V-I region HK101 ProteinP01601 (Uniprot-TrEMBL)
Ig kappa chain V-I region Wes ProteinP01611 (Uniprot-TrEMBL)
Ig kappa chain V-II region Cum ProteinP01614 (Uniprot-TrEMBL)
Ig kappa chain V-II region FR ProteinP01615 (Uniprot-TrEMBL)
Ig kappa chain V-II region RPMI 6410 ProteinP06310 (Uniprot-TrEMBL)
Ig kappa chain V-III region B6 ProteinP01619 (Uniprot-TrEMBL)
Ig kappa chain V-III region POM ProteinP01624 (Uniprot-TrEMBL)
Ig kappa chain V-III region VG ProteinP04433 (Uniprot-TrEMBL)
Ig lambda chain V region 4A ProteinP04211 (Uniprot-TrEMBL)
Ig lambda chain V-I region HA ProteinP01700 (Uniprot-TrEMBL)
Ig lambda chain V-I region NEW ProteinP01701 (Uniprot-TrEMBL)
Ig lambda chain V-I region NEWM ProteinP01703 (Uniprot-TrEMBL)
Ig lambda chain V-I region VOR ProteinP01699 (Uniprot-TrEMBL)
Ig lambda chain V-II region BOH ProteinP01706 (Uniprot-TrEMBL)
Ig lambda chain V-II region MGC ProteinP01709 (Uniprot-TrEMBL)
Ig lambda chain V-II region NEI ProteinP01705 (Uniprot-TrEMBL)
Ig lambda chain V-II region TOG ProteinP01704 (Uniprot-TrEMBL)
Ig lambda chain V-III region LOI ProteinP80748 (Uniprot-TrEMBL)
Ig lambda chain V-III region SH ProteinP01714 (Uniprot-TrEMBL)
Ig lambda chain V-IV region Bau ProteinP01715 (Uniprot-TrEMBL)
Ig lambda chain V-IV region Hil ProteinP01717 (Uniprot-TrEMBL)
Ig lambda chain V-IV region Kern ProteinP01718 (Uniprot-TrEMBL)
Ig lambda chain V-VI region AR ProteinP01721 (Uniprot-TrEMBL)
IgG:LPG1G2ComplexR-HSA-9675736 (Reactome)
IgG:Leishmania surface:FCGR3AComplexR-HSA-9666434 (Reactome)
IgG:Leishmania

surface:FCGR3Ap-CD3

dimers:p-6Y-SYK:VAV1,2,3:PI(3,4,5)P3		ComplexR-HSA-9666421 (Reactome)
IgG:Leishmania surface:p-FCGR3A:p-6Y-SYK:CRKII:DOCK180:ELMOComplexR-HSA-9666431 (Reactome)
IgG:Leishmania surface:p-FCGR3A:p-6Y-SYK:p-VAV1,2,3:PI(3,4,5)P3ComplexR-HSA-9666423 (Reactome)
IgG:Lma

antigens:FCGR3A:CD3

dimers		ComplexR-HSA-9664263 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimers:SYKComplexR-HSA-9664272 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimers:p-6Y-SYKComplexR-HSA-9664265 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimersComplexR-HSA-9664282 (Reactome)
IgG:Lma amastigote surfaceComplexR-HSA-9664283 (Reactome)
IgG:Lma antigensComplexR-HSA-9666422 (Reactome)
IgGComplexR-HSA-182629 (Reactome) In view of the highly variable nature of antibody proteins, this biological object is an approximate and fragmented representation of an IgM/IgD antibody, given the limitations of Ig chain enumeration in UniProt. A single mRNA transcript is alternatively spliced to give either IgM or IgD. Thus unactivated B cells contain both classes of antibody.
IgH heavy chain V-III region VH26 precursor ProteinP01764 (Uniprot-TrEMBL)
LPG1G2 ProteinQ4QD44 (Uniprot-TrEMBL)
LPG1G2ProteinQ4QD44 (Uniprot-TrEMBL)
LYN ProteinP07948 (Uniprot-TrEMBL)
Lma amastigote surfaceR-LMA-9664274 (Reactome) This entity is intended to represent any molecule that might be at the outer cell surface of a Leishmania amastigote parasite.
Lma amastigote surface R-LMA-9664274 (Reactome) This entity is intended to represent any molecule that might be at the outer cell surface of a Leishmania amastigote parasite.
MYH2 ProteinQ9UKX2 (Uniprot-TrEMBL)
MYH9 ProteinP35579 (Uniprot-TrEMBL)
MYO10 ProteinQ9HD67 (Uniprot-TrEMBL)
MYO1C ProteinO00159 (Uniprot-TrEMBL)
MYO5A ProteinQ9Y4I1 (Uniprot-TrEMBL)
MYO9B ProteinQ13459 (Uniprot-TrEMBL)
Mother filament:ARP2/3:actin:ADPComplexR-HSA-2197686 (Reactome)
Mother

filament:branching complex:daughter

filament		ComplexR-HSA-1861699 (Reactome)
Mother

filament:branching

complex		ComplexR-HSA-2029140 (Reactome)
Myosin-Actin filamentsComplexR-HSA-2029139 (Reactome)
Myosin-X dimerComplexR-HSA-1861665 (Reactome)
MyosinComplexR-HSA-2029109 (Reactome)
N-WASP ProteinO00401 (Uniprot-TrEMBL)
NCK1 ProteinP16333 (Uniprot-TrEMBL)
NCKAP1 ProteinQ9Y2A7 (Uniprot-TrEMBL)
NCKAP1L ProteinP55160 (Uniprot-TrEMBL)
NCKIPSD ProteinQ9NZQ3 (Uniprot-TrEMBL)
PI(3,4)P2 MetaboliteCHEBI:16152 (ChEBI)
PI(3,4)P2MetaboliteCHEBI:16152 (ChEBI)
PI(3,4,5)P3 MetaboliteCHEBI:16618 (ChEBI)
PI(3,4,5)P3MetaboliteCHEBI:16618 (ChEBI)
PI(4,5)P2 MetaboliteCHEBI:18348 (ChEBI)
PI(4,5)P2:WASP/N-WASPComplexR-HSA-9667225 (Reactome)
PI(4,5)P2MetaboliteCHEBI:18348 (ChEBI)
PIP3:VAV1,2,3ComplexR-HSA-5340329 (Reactome)
PTK2 ProteinQ05397 (Uniprot-TrEMBL)
PiMetaboliteCHEBI:43474 (ChEBI)
RAC1 ProteinP63000 (Uniprot-TrEMBL)
RAC1:GDPComplexR-HSA-5674631 (Reactome)
RAC1:GTPComplexR-HSA-442641 (Reactome)
SH3 domain proteinsComplexR-HSA-2197679 (Reactome)
SRC-1 ProteinP12931-1 (Uniprot-TrEMBL)
SYK ProteinP43405 (Uniprot-TrEMBL)
SYKProteinP43405 (Uniprot-TrEMBL)
Src family kinases (SFKs)ComplexR-HSA-1861597 (Reactome)
Src-kinasesComplexR-HSA-2197681 (Reactome)
Unknown GEFR-HSA-8939797 (Reactome)
VAV1 ProteinP15498 (Uniprot-TrEMBL)
VAV1,2,3ComplexR-HSA-430172 (Reactome)
VAV2 ProteinP52735 (Uniprot-TrEMBL)
VAV3 ProteinQ9UKW4 (Uniprot-TrEMBL)
WAS ProteinP42768 (Uniprot-TrEMBL)
WASF1 ProteinQ92558 (Uniprot-TrEMBL)
WASF2 ProteinQ9Y6W5 (Uniprot-TrEMBL)
WASF3 ProteinQ9UPY6 (Uniprot-TrEMBL)
WASP/N-WASPComplexR-HSA-201892 (Reactome)
WAVE Regulatory ComplexComplexR-HSA-2029154 (Reactome)
WAVE2, WASP,

N-WASP:ARP2/3

complex:G-actin		ComplexR-HSA-442565 (Reactome)
WAVE2, WASP, N-WASPComplexR-HSA-2197675 (Reactome)
WIP family proteinsComplexR-HSA-2197678 (Reactome)
WIPF1 ProteinO43516 (Uniprot-TrEMBL)
WIPF2 ProteinQ8TF74 (Uniprot-TrEMBL)
WIPF3 ProteinA6NGB9 (Uniprot-TrEMBL)
WRC:IRSp53/58:RAC1:GTP:PIP3ComplexR-HSA-2029147 (Reactome)
YES1 ProteinP07947 (Uniprot-TrEMBL)
p-4S-ABI2 ProteinQ9NYB9 (Uniprot-TrEMBL)
p-5S-ABI1 ProteinQ8IZP0 (Uniprot-TrEMBL)
p-6Y-CD247 ProteinP20963-1 (Uniprot-TrEMBL)
p-6Y-SYK ProteinP43405 (Uniprot-TrEMBL)
p-T,Y MAPK dimersComplexR-HSA-1268261 (Reactome)
p-T185,Y187-MAPK1 ProteinP28482 (Uniprot-TrEMBL)
p-T202,Y204-MAPK3 ProteinP27361 (Uniprot-TrEMBL)
p-Y,S,T-WRC:IRSp53/58:RAC1:GTP:PIP3ComplexR-HSA-2029148 (Reactome)
p-Y-WRC:IRSp53/58:RAC1:GTP:PIP3ComplexR-HSA-2130182 (Reactome)
p-Y150,S343,T346-WASF2 ProteinQ9Y6W5 (Uniprot-TrEMBL)
p-Y150-WASF2 ProteinQ9Y6W5 (Uniprot-TrEMBL)
p-Y151,S,T-WASF1 ProteinQ92558 (Uniprot-TrEMBL)
p-Y151,S,T-WASF3 ProteinQ9UPY6 (Uniprot-TrEMBL)
p-Y151-WASF1 ProteinQ92558 (Uniprot-TrEMBL)
p-Y151-WASF3 ProteinQ9UPY6 (Uniprot-TrEMBL)
p-Y160,Y171-CD3G ProteinP09693 (Uniprot-TrEMBL)
p-Y172-VAV2 ProteinP52735 (Uniprot-TrEMBL)
p-Y173-VAV3 ProteinQ9UKW4 (Uniprot-TrEMBL)
p-Y174-VAV1 ProteinP15498 (Uniprot-TrEMBL)
p-Y256-WASL ProteinO00401 (Uniprot-TrEMBL)
p-Y291-WAS ProteinP42768 (Uniprot-TrEMBL)

Annotated Interactions

View all...
SourceTargetTypeDatabase referenceComment
ABL1mim-catalysisR-HSA-2130194 (Reactome)
ADPArrowR-HSA-2029469 (Reactome)
ADPArrowR-HSA-2130194 (Reactome)
ADPArrowR-HSA-2197698 (Reactome)
ADPArrowR-HSA-9664261 (Reactome)
ADPArrowR-HSA-9664275 (Reactome)
ADPArrowR-HSA-9666425 (Reactome)
ADPArrowR-HSA-9666458 (Reactome)
ARP2/3 complex (ATP bound)R-HSA-442592 (Reactome)
ATPR-HSA-1861595 (Reactome)
ATPR-HSA-2029469 (Reactome)
ATPR-HSA-2130194 (Reactome)
ATPR-HSA-2197698 (Reactome)
ATPR-HSA-9664261 (Reactome)
ATPR-HSA-9664275 (Reactome)
ATPR-HSA-9666425 (Reactome)
ATPR-HSA-9666458 (Reactome)
Actin filament bound Myosin-XArrowR-HSA-1861595 (Reactome)
BAIAP2R-HSA-2029465 (Reactome)
CDC42:GDPR-HSA-2029445 (Reactome)
CDC42:GTP:WASP/N-WASP:WIP:SH3 proteinsArrowR-HSA-2197691 (Reactome)
CDC42:GTP:WASP/N-WASP:WIP:SH3 proteinsR-HSA-2197698 (Reactome)
CDC42:GTP:WASP/N-WASPArrowR-HSA-442586 (Reactome)
CDC42:GTP:WASP/N-WASPArrowR-HSA-9670155 (Reactome)
CDC42:GTP:WASP/N-WASPR-HSA-2197691 (Reactome)
CDC42:GTP:p-Y-WASP/p-Y-WASL:WIP:SH3 proteinsArrowR-HSA-2197698 (Reactome)
CDC42:GTPArrowR-HSA-2029445 (Reactome)
CDC42:GTPR-HSA-442586 (Reactome)
CDC42:GTPR-HSA-9670155 (Reactome)
CRK:DOCK180:ELMO1,ELMO2R-HSA-9666426 (Reactome)
F-actinR-HSA-2029466 (Reactome)
FCGRIIIA:CD3G/CD3Z dimersR-HSA-9664406 (Reactome)
G-actinR-HSA-2029473 (Reactome)
G-actinR-HSA-442592 (Reactome)
GDPArrowR-HSA-2029445 (Reactome)
GDPArrowR-HSA-9666428 (Reactome)
GDPArrowR-HSA-9666430 (Reactome)
GTPR-HSA-2029445 (Reactome)
GTPR-HSA-9666428 (Reactome)
GTPR-HSA-9666430 (Reactome)
IgG:LPG1G2ArrowR-HSA-9664397 (Reactome)
IgG:Leishmania surface:FCGR3AArrowR-HSA-9666458 (Reactome)
IgG:Leishmania

surface:FCGR3Ap-CD3

dimers:p-6Y-SYK:VAV1,2,3:PI(3,4,5)P3		ArrowR-HSA-9666435 (Reactome)
IgG:Leishmania

surface:FCGR3Ap-CD3

dimers:p-6Y-SYK:VAV1,2,3:PI(3,4,5)P3		R-HSA-9666425 (Reactome)
IgG:Leishmania surface:p-FCGR3A:p-6Y-SYK:CRKII:DOCK180:ELMOArrowR-HSA-9666426 (Reactome)
IgG:Leishmania surface:p-FCGR3A:p-6Y-SYK:CRKII:DOCK180:ELMOmim-catalysisR-HSA-9666428 (Reactome)
IgG:Leishmania surface:p-FCGR3A:p-6Y-SYK:p-VAV1,2,3:PI(3,4,5)P3ArrowR-HSA-9666425 (Reactome)
IgG:Leishmania surface:p-FCGR3A:p-6Y-SYK:p-VAV1,2,3:PI(3,4,5)P3mim-catalysisR-HSA-9666430 (Reactome)
IgG:Lma

antigens:FCGR3A:CD3

dimers		ArrowR-HSA-9664406 (Reactome)
IgG:Lma

antigens:FCGR3A:CD3

dimers		R-HSA-9664275 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimers:SYKArrowR-HSA-9664273 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimers:SYKR-HSA-9664261 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimers:p-6Y-SYKArrowR-HSA-9664261 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimers:p-6Y-SYKR-HSA-9666426 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimers:p-6Y-SYKR-HSA-9666435 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimers:p-6Y-SYKmim-catalysisR-HSA-9666425 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimersArrowR-HSA-9664275 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimersR-HSA-9664273 (Reactome)
IgG:Lma antigens:FCGR3A:p-CD3 dimersR-HSA-9666458 (Reactome)
IgG:Lma amastigote surfaceArrowR-HSA-9666433 (Reactome)
IgG:Lma antigensR-HSA-9664406 (Reactome)
IgGR-HSA-9664397 (Reactome)
IgGR-HSA-9666433 (Reactome)
LPG1G2R-HSA-9664397 (Reactome)
Lma amastigote surfaceR-HSA-9666433 (Reactome)
Mother filament:ARP2/3:actin:ADPArrowR-HSA-2197690 (Reactome)
Mother filament:ARP2/3:actin:ADPR-HSA-2029473 (Reactome)
Mother

filament:branching complex:daughter

filament		ArrowR-HSA-2029473 (Reactome)
Mother

filament:branching complex:daughter

filament		R-HSA-1861595 (Reactome)
Mother

filament:branching complex:daughter

filament		R-HSA-9666458 (Reactome)
Mother

filament:branching

complex		ArrowR-HSA-2029466 (Reactome)
Mother

filament:branching

complex		R-HSA-2197690 (Reactome)
Myosin-Actin filamentsArrowR-HSA-9666458 (Reactome)
Myosin-X dimerR-HSA-1861595 (Reactome)
Myosin-X dimermim-catalysisR-HSA-1861595 (Reactome)
MyosinR-HSA-9666458 (Reactome)
PI(3,4)P2R-HSA-1861595 (Reactome)
PI(3,4,5)P3R-HSA-2029465 (Reactome)
PI(3,4,5)P3R-HSA-434637 (Reactome)
PI(4,5)P2:WASP/N-WASPArrowR-HSA-9670156 (Reactome)
PI(4,5)P2:WASP/N-WASPR-HSA-9670155 (Reactome)
PI(4,5)P2R-HSA-442586 (Reactome)
PI(4,5)P2R-HSA-9670156 (Reactome)
PIP3:VAV1,2,3ArrowR-HSA-434637 (Reactome)
PIP3:VAV1,2,3R-HSA-9666435 (Reactome)
PiArrowR-HSA-1861595 (Reactome)
PiArrowR-HSA-9666458 (Reactome)
R-HSA-1861595 (Reactome) Myosin-X (Myosin 10) is one of the downstream effectors of PI3K in FCGR-phagocytosis and is involved in pseudopod extension and closure of phagocytic cups. It is recruited to the forming phagosome by binding, through its second PH domain to membrane PIP3, a major product of PI3-kinase (Cox et al. 2002). Myosin-X may act as a motor to transport membrane cargo molecules to the forming pseudopods, influencing actin dynamics. It is not understood with certainty how myosin X contributes to the mechanism of pseudopod extension. It selectively binds to actin bundle such that each head may bind, in an ATP-sensitive manner, to two adjacent actin filaments within the actin bundle. Myosin X hydrolyze ATP and converts this chemical energy to mechanical energy moving toward the plus end/barbed end of the actin filament facing towards the tip of the growing pseudopods (Araki 2006, Chavrier 2003, Watanabe et al 2010).
R-HSA-2029445 (Reactome) FCGR mediated phagocytosis requires CDC42 to stimulate actin polymerization, generating the force for phagocytic cup protrusion or pseudopod extension. CDC42 activation is restricted at the advancing edge of the phagocytic cup, where actin is concentrated, and is deactivated at the base of the phagocytic cup (Beemiller et al 2010). The mechanism behind the recruitment and activation of CDC42 during FCGR phagocytosis is unknown. VAV regulates the activation of RAC1 but not CDC42 and the GEF responsible for CDC42 activation during FCGR-mediated phagocytosis remains unidentified (Adam et al 2004, Patel et al 2002).
R-HSA-2029465 (Reactome) WASP family verprolin-homologous proteins (WAVEs) function downstream of RAC1 and are involved in activation of the ARP2/3 complex. The resulting actin polymerization mediates the projection of the plasma membrane in lamellipodia and membrane ruffles. WAVEs exist as a pentameric hetero-complex called WAVE Regulatory Complex (WRC). The WRC consists of a WAVE family protein (WASF1, WASF2 or WASF3 - commonly known as WAVE1, WAVE2 or WAVE3), ABI (Abelson-interacting protein), NCKAP1 (NAP1, p125NAP1), CYFIP1 (SRA1) or the closely related CYFIP2 (PIR121), and BRK1 (HSPC300, BRICK). Of the three structurally conserved WAVEs in mammals, the importance of WAVE2 in activation of the ARP2/3 complex and the consequent formation of branched actin filaments is best established. WAVEs in the WRC are intrinsically inactive and are stimulated by RAC1 GTPase and phosphatidylinositols (PIP3). The C-terminal VCA domain of WAVE2 (and likely WAVE1 and WAVE3) which can bind both the ARP2/3 complex and actin monomers (G-actin) is masked in the inactive state. After PIP3 binds to the polybasic region of WAVE2 (and likely WAVE1 and WAVE3) and RAC1:GTP binds to the CYFIP1 (or CYFIP2) subunit of the WRC, allosteric changes most likely occur which allow WAVEs to interact with the ARP2/3 complex. The interactions between WAVEs and RAC1 are indirect. BAIAP2/IRSp53, an insulin receptor substrate, acts as a linker, binding both activated RAC1 and the proline-rich region of WAVE2 (and likely WAVE1 and WAVE3) and forming a trimolecular complex. CYFIP1 (or CYFIP2) in the WAVE regulatory complex binds directly to RAC1:GTP and links it to WAVE2 (and likely WAVE1 and WAVE3) (Derivery et al. 2009, Yamazaki et al. 2006, Takenawa & Suetsugu 2007, Chen et al. 2010, Pollard 2007, Lebensohn & Kirschner 2009).
R-HSA-2029466 (Reactome) Once activated, the ARP2/3 complex nucleates new actin filaments that extend from the sides of pre-existing mother actin filaments at a 70-degree angle to form Y-branched networks (Firat-Karalar & Welch 2010). These branched actin filaments push the cell membrane forward to form a pseudopod. The ARP2/3 complex is composed of two Arps (actin-related proteins), ARP2 and ARP3, and five unique proteins ARPC1, ARPC2, ARPC3, ARPC4 and ARPC5 (Gournier et al. 2001). Both ARP2 and ARP3 subunits bind ATP. There are two proposed models to explain the process of actin nucleation by ARP2/3 complex: the barbed-end branching model and the dendritic nucleation/side branching model (Le Clainche & Carlier 2008).
In barbed-end branching model, the branching/ternary complex (G-actin-WASP/WAVE-Arp2/3 complex) binds to the barbed end of the mother filament. G-actin bound to VCA domain or one of the Arp subunits incorporates into the mother filament at the barbed end, thus positioning ARP2/3 complex to initiate the daughter branch on the side of the mother filament. ARP2/3 nucleates the formation of new actin filament branches, which elongate at the barbed ends (Le Clainche & Carlier 2008, Pantaloni et al 2000, Le Clainche et al. 2003, Egile et al. 2005). In side branching model, the branching complex binds to the side of the mother actin filament mimicking an actin nucleus and initiates a lateral branch (Le Clainche & Carlier 2008, Amann & Pollard 2001).
R-HSA-2029469 (Reactome) The ARP2/3 complex shows higher affinity for the phosphorylated VCA domain of WAVE2 than for the unphosphorylated VCA domain. WAVE proteins can be phosphorylated by various kinases. Active ERK (Mitogen activated protein kinase 3) phosphorylates the WAVE regulatory complex (WRC) on multiple serine/threonine sites within the proline-rich domains (PRDs) of WAVE2 and ABI1. Phosphorylation of the PRDs would disrupt their interaction with SH3 and PLP binding domains, potentially altering WRC activation. ERK phosphorylates both S343 and T346 in WAVE2 and S183, S216, S225, S392, and S410 in ABI1. Cumulatively, the phosphorylation of both WAVE2 and ABI in the WAVE regulatory complex (WRC) contributes to the RAC-induced WRC conformational change that exposes the VCA domain, leading to binding and activation of ARP2/3 (Mendoza et al. 2011, Nakanishi et al. 2007). ERK phosphorylation sites in WAVE2 are not strictly conserved in WAVE1 and WAVE3 but, based on the amino acid sequence, other potential ERK phosphorylation sites exist.
R-HSA-2029473 (Reactome) ATP bound G-actin monomers are added to the fast growing barbed ends of both mother and daughter filaments. The polymerization of these filaments drives membrane protrusion. In the process of phagocytosis, pseudopodia extend around the antibody-bound particle to form the phagocytic cup. This elongation continues until the filament reaches steady state equilibrium with free G-actin monomers (Millard et al. 2004, Le Clainche et al. 2008).
R-HSA-2130194 (Reactome) Abelson interactor-1 (ABL) tyrosine kinase phosphorylates the strictly conserved tyrosine 150 in WAVE2 (Y151 in WAVE1 and WAVE3) (Leng et al. 2003, Chen et al. 2010).
R-HSA-2197690 (Reactome) After incorporation at the branch, the actin bound to VCA domain of WASP/WAVE undergoes ATP hydrolysis and this destabilizes its interaction with WASP/WAVE. This dissociates the branched junction from the membrane-bound WASP/WAVE (Kovar 2006).
R-HSA-2197691 (Reactome) WASP interacting proteins (WIP) family includes WIPF1 (WIP), WIPF2 (WIRE,WICH) and WIPF3 (CR16, corticosteroids and regional expression-16). WIPs share a specific proline rich sequence that interacts with the WH1 domain of WASP and N-WASP (WASL). WIPs form heterocomplexes with WASPs and may contribute to the WASP protein stability (Aspenstrom 2002, Kato et al. 2002, Ho et al. 2001, Moreau et al. 2000).
SH3 domain containing adaptor proteins like GRB2 (Carlier et al. 2000), NCK (Rohatgi et al. 2001) and WISH (DIP/SPIN90) (Fukuoka et al. 2001) bind to the proline rich domain in WASPs and activate the ARP2/3 complex. By binding simultaneously to N-WASP and the ARP2/3 complex, GRB2 works synergistically with CDC42 in the activation of ARP2/3 complex-mediated actin assembly (Carlier et al. 2000).
R-HSA-2197698 (Reactome) WASP is phosphorylated on Tyr291 (Cory et al. 2002) and N-WASP (WASL) on Tyr256 (Wu et al. 2004) by Src family of tyrosine kinases and this phosphorylation may release the autoinhibitory intramolecular interactions. The phosphorylation seems to be enhanced by the activation of CDC42. WASP phosphorylation and binding of CDC42 have a synergistic effect on the activation of the ARP2/3 complex (Takenawa & Suetsugu 2007). In N-WASP, the phosphorylation may reduce its nuclear translocation and may sustain it in its functional site in the cytoplasm (Wu et al. 2004).
R-HSA-434637 (Reactome) Vav interacts directly with PIP2 and PIP3, with a fivefold selectivity for PIP3 over PIP2. PIP3 gives a twofold stimulation of Vav1 GEF activity while PIP2 leads to 90% inhibition. Binding probably occurs through the PH domain, known to bind phosphoinositides.
R-HSA-442586 (Reactome) Wiskott-Aldrich syndrome protein (WASP) and Neural-WASP (N-WASP, WASL) proteins are scaffolds that transduce signals from cell surface receptors to the activation of the ARP2/3 complex and actin polymerization. WASP and N-WASP possess a central GTPase binding domain (GBD) and an NH2-terminal WASP homology domain 1 (WH1) followed by a basic region (B), and a C-terminal VCA region that contains: a V domain (verprolin homology/WASP homology 2), a C domain (connecting), and an A motif (acidic). The VCA region is responsible for binding to and activating the ARP2/3 complex (Bompard & Caron 2004, Callebaut et al 1998). Under resting conditions, WASP and N-WASP are maintained in an autoinhibited state via interaction of the GBD and the VCA domains. This prevents access of the ARP2/3 complex and G-actin to the VCA region. Activated CDC42 binds to the GBD region of WASPs and this interaction releases the VCA region from autoinhibition, enabling binding of the ARP2/3 complex and stimulating actin polymerization (Kim et al 2000, Park & Cox 2009). Phosphoinositides (PtdIns(4,5)P2) interact with the basic (B) region in WASPs and this interaction is important for activation of the WASPs and the ARP2/3 complex (Higgs & Pollard 2000).
R-HSA-442592 (Reactome) Once WASPs (WASP and N-WASP) and WAVEs (WAVE2 and probably WAVE1 and WAVE3) are activated, their VCA region becomes available for binding to the ARP2/3 complex and actin monomer (G-actin). The actin monomer binds to the V domain and ARP2/3 complex binds to the CA domain. The simultaneous binding of G-actin and the ARP2/3 complex to the VCA region contributes to the activation of the ARP2/3-complex-mediated actin polymerization. The VCA module acts as a platform on which an actin monomer binds to the ARP2/3 complex to trigger actin polymerization (Takenawa & Suetsugu 2007).
R-HSA-9664261 (Reactome) Multiple sites of phosphorylation are known to exist in SYK, which both regulate its activity and also serve as docking sites for other proteins. Some of these sites include Y131 of interdomain A, Y323, Y348, and Y352 of interdomain B, and Y525 and Y526 within the activation loop of the kinase domain and Y630 in the C-terminus (Zhang et al. 2002, Lupher et al. 1998, Furlong et al. 1997). Phosphorylation of these tyrosine residues disrupts autoinhibitory interactions and results in kinase activation even in the absence of phosphorylated ITAM tyrosines (Tsang et al. 2008). SYK is primarily phosphorylated by Src family kinases and this acts as an initiating trigger by generating few molecules of activated SYK which are then involved in major SYK autophosphorylation (Hillal et al. 1997).
R-HSA-9664273 (Reactome) SYK is a tyrosine kinase related to ZAP70 that is expressed in all hematopoietic cells and coimmunoprecipitates with the gamma chain associated with FCGRIIIA in macrophages and with FCERI in mast cells. SYK is very important for FCGR phagocytosis and is recruited to these phosphorylated ITAM residues through its two SRC homology 2 (SH2) domains (Agarwal et al. 1993). When SYK kinase expression is inhibited with antisense oligonucleotides both in vitro and in vivo, phagocytosis and inflammation are abolished (Matsuda et al. 1997). The domain structure of SYK comprises a regulatory region at the N-terminus consisting of a pair of SH2 domains separated by an inter-SH2 linker called interdomain A, an SH2-domain-kinase linker termed interdomain B, and a C-terminal kinase domain (Arias-Palomo et al. 2009). In resting state SYK exists in an auto-inhibited conformation by the interactions between the SH2-SH2 regulatory region and the inter-SH2 linker and the catalytic domain. This interdomain interaction reduces the conformational flexibility required by the kinase domain for catalysis (Arias-Palomo et al. 2007). Changes in the orientation of the SH2 domains could control the disruption of the auto inhibitory interactions and the activation of SYK. These movements could be totally or partially induced by the binding to phosphorylated ITAMs and/or phosphorylation of tyrosine residues in interdomain A or B (Arias-Palomo et al. 2009). Tsang et al. suggested that SYK functions as an OR-gate switch with respect to phosphorylation and ITAM binding, as either one stimulus OR the other is sufficient to cause full activation (Tsang et al. 2008).
R-HSA-9664275 (Reactome) After cross linking, Fc gamma receptors are sequestered to lipid rafts where they are complexed with some of the tyrosine kinases of Src family and undergo phosphorylation on the tyrosine residues contained in conserved ITAM sequences. At least six out of nine members of the Src family kinases (SRC, FYN, FGR, HCK, YES and LYN ) have been identified in the phagocytic cells and are implicated in the initiation of Fc gamma mediated signaling. (Suzuki et al. 2000, Majeed et al. 2001, Kwiatkowska et al. 2003). Some of these kinases have been found associated with specific receptors. In monocytes HCK and LYN have been found associated with FCGRI (Durden et al. 1995), whereas only HCK with FCGRIIA (Ghazizadeh et al. 1994) while FGR in neutrophils (Hamada et al. 1993) and LCK in NK cells with FCGRIIIA (Pignata et al. 1993)
The implication of Src kinases in phosphorylation was first supported by pharmacological findings that herbimycin A, a tyrosine kinase inhibitor relatively specific for Src-family kinases, potently suppressed Fc receptor mediated functions (Greenberg et al. 1993, Suzuki et al. 2000). However, their particular involvement in phagocytosis remains unclear, as targeted disruption of single or multiple Src family genes did not result in significant alterations in phagocytosis (Hunter et al. 1993, Fitzer Attas et al. 2000, Suzuki et al. 2000). HCK, FGR and LYN triple-deficient (-/-) macrophages have shown significant delays in FCGR mediated phagocytosis, but these deficiencies do not completly disrupt the process (Fitzer Attas et al. 2000).
Tyrosine residues Y288 and Y304 (Y282 and Y298 according to the literature reference, it is 6 residues shorter compared to uniprot entry due to an alternate initiation codon usage), within ITAM sequence in the cytoplasmic domain of FCGRIIA are the key target sites that are phosphorylated by Src family kinases (Mitchell et al, 1994). In case of FCGRIA and FCGRIIIA the specific tyrosine residues within ITAMs of the associated gamma/zeta chains are phosphorylated by activated Src family kinases (SFKs) (Park et al. 1993).
R-HSA-9664397 (Reactome) The internalization of Leishmania amastigotes by macrophages is thought to be mediated mainly through opsonization with immunoglobulins (Igs) which bind FcγRs, stimulating the uptake (Morehead et al 2002 & Padigel et al. 2005). Glycoinositol phospholipids (GIPLs) are the most abundant glycolipids on the surface of the amastigote form of Leishmania parasites and Buxbaum and colleagues showed that IgG1 in mice, binds the GIPL molecules on the amastigote stage of L. mexicana to subsequently induced the phagocytosis through FcγRs (Buxbaum 2013).
R-HSA-9664406 (Reactome) FCGRIII (CD16) is a low affinity Fc gamma receptor and is encoded by two genes (A and B), the transmembrane form FCGRIIIA and the GPI anchored FCGRIIIB (Edberg et al. 1989). FCGRIIIA is involved in phagocytosis and is expressed in macrophages and natural killer cells as a multi chain complex consisting of a single alpha chain containing IgG binding domains and a signal transducing gamma and/or zeta dimer (Wirthmuller et al. 1992, Lanier et al. 1989, Garcia Garcia & Rosales 2002). Both gamma and zeta chains contain a conserved immunoreceptor tyrosine based activation motif (ITAM), which has 2 copies of the YXXL sequence (Isakov 1997). However, the gamma chain of FCGRIIIA is approximately sixfold more efficient in mediating phagocytosis than the zeta subunit (Park & Schreiber 1995). Phosphorylation of the conserved tyrosine residues of the ITAM in these accessory proteins is required for the phagocytic signal mediated by FCRGIIIA.
The first step in Fc-gamma receptor (FCGR) phagocytosis is binding and clustering of FCGRs by IgG-coated foreign particles (For this particular pathway the coated foreing particle is the Leishmania parasite). FCGR are clustered at the cell surface by multivalent antigen-antibody complexes and recruited to lipid raft micro domains; monovalent ligand binding is insufficient to generate a signal.
This cross linking results in the localisation of FCGRs into lipid rafts and this may aid in their recruiting and complexing with additional signalling proteins associated with lipid rafts (Kono et al. 2002). This is followed by phosphorylation of the tyrosine residues within the ITAM located on the cytoplasmic portion of accessory gamma/zeta chains by membrane associated tyrosine kinases of the Src family (Park et al. 1993).
R-HSA-9666425 (Reactome) VAV proteins exist in an auto-inhibitory state folded in such a way as to inhibit the GEF activity of its DH domain. This folding is mediated through binding of tyrosines in the acidic domain to the DH domain and through binding of the CH domain to the C1 region. Activation of VAV may involve at least three different events to relieve this auto-inhibition. Phosphorylation of the tyrosines in the acidic domain causes them to be displaced from the DH domain, binding of a ligand to the CH domain may cause it to release the C1 domain and binding of PIP3 to PH domain may alter its conformation. VAV1 is phosphorylated on Y174 in the acidic domain, and this is mediated by Syk and Src-family tyrosine kinases. Once activated, VAV1 is then involved in the activation of RAC and CDC42 downstream of FCGR.
R-HSA-9666426 (Reactome) Macrophages lacking all the three isoforms of VAV did not affect FCGR-mediated phagocytosis suggesting that RAC1 is regulated by GEFs other than VAV downstream of the FCGR (Hall et al 2006). DOCK180, a member of GEFs, is found to be involved in the activation of RAC1. DOCK180 associates with the adaptor protein CRKII and the complex is found to accumulate at the phagocytic cup. DOCK180 is recruited to the sites of phagocytosis by binding to SH3 domain of CRKII through its proline-rich motif (Hasegawa et al 1996). CRKII is likely recruited to the activated FCGR complex by binding phosphorylated ITAM tyrosines on the receptor or through other phosphotyrosines on ancillary proteins that are recruited to the receptor complex (Lee et al 2007). Unlike the usual GEFs, DOCK180 does not contain the conserved Dbl homology (DH) domain. Instead, it has a DHR-2 or DOCKER domain capable of loading RAC with GTP (Brugnera et al 2002). Binding of DOCK180 to RAC alone is insufficient for GTP loading, and a DOCK180-ELMO interaction is required. ELMO1, as well as ELMO2, form a complex with DOCK180 and they function together as a bipartite GEF to optimally activate RAC (Gumienny et al 2001, Brugnera et al 2002).
R-HSA-9666428 (Reactome) RAC1 is activated from inactive GDP-bound state to active GTP-bound form by the GEF activity of DOCK180:ELMO complex.
R-HSA-9666430 (Reactome) The organized movements of membranes and the actin cytoskeleton are coordinated in phagocytosis by small GTPases of the Rho family. Specifically, RAC1 and CDC42 are known to be stimulated upon engagement of FCGR and are essential for the extension of the pseudopods that surround and engulf the phagocytic particle (Scott et al 2005). RAC1 is known to regulate actin dynamics. It is active throughout the phagocytic cup and activated RAC1 is necessary to assemble F actin. However, closing the phagocytic cup requires RAC1 to be deactivated (Naakaya et al 2007). Deletion of RAC1 prevents FCGR mediated phagocytosis (Hall et al 2006). RAC1 activation involves transition from an inactive GDP bound to an active GTP bound state catalysed by guanine exchanges factors (GEFs). VAV has been implicated in the activation of RAC1 (Patel et al 2002).
R-HSA-9666433 (Reactome) The internalization of Leishmania amastigotes by macrophages is thought to be mediated mainly through opsonization with immunoglobulins (Igs) which bind Fc gamma receptors (FCGRs), stimulating their uptake (Morehead et al 2002 & Padigel et al. 2005). Glycoinositol phospholipids (GIPLs) are the most abundant glycolipids on the surface of the amastigote form of Leishmania parasites and Buxbaum and colleagues showed that IgG1 in mice binds GIPL molecules on the amastigote stage of L. mexicana to subsequently induce phagocytosis through FCGRs (Buxbaum 2013).
R-HSA-9666435 (Reactome) VAV family members are cytoplasmic guanine nucleotide exchange factors (GEFs) for Rho-family GTPases (RAC, RHO and CDC42). VAV1 is found predominantly in hematopoietic cells, whereas VAV2 and VAV3 are more broadly expressed. VAV proteins link the cell surface receptors like FCGR to the intracellular Rho GTPases and the actin cytoskeleton during phagocytosis (Hall et al 2006). Experiments using two-hybrid system suggest that VAV1 with its SH2 domain directly binds to the phosphorylated Y342 of SYK (Deckert et al. 1996). VAV proteins are also recruited to membrane through their PH domain by binding PI(3,4,5)P3 produced by PI3K.
R-HSA-9666458 (Reactome) In addition to the membrane remodeling for pseudopod extension, particle internalization requires a contractility force pulling the forming phagosome into the cytoplasm. Myosin motor proteins are the actin-binding proteins, with ATPase activity move along actin fibers, and produce the driving force for phagosome formation and transport. Several myosin motors including myosins IC, II, V, IXb are involved in FCGR-mediated phagocytosis as force generators and actin-based transport motors (Swanson et al. 1999). Nonmuscle myosin II, is a motor protein known to generate intracellular contractile forces and tension by associating with F-actin. It has been observed to localize around forming phagosomes and suggested a role in phagocytic-cup squeezing during FCGR-mediated phagocytosis. Each myosin II motor protein exists as a complex consisting of two copies each of myosin II heavy chain (MHC), essential light chains (ELC), and myosin regulatory light chain (MRLC). Selective inhibition of myosin II by ML-7, a myosin light-chain kinase (MLCK) inhibitor, prevents phagocytic cup closure, but not pseudopod extension for the formation of phagocytic cups in FCGR-mediated phagocytosis (Grooves et al. 2008, Araki 2006). Tight ring of actin filaments within the elongating pseudopodia squeezes the deformable particles. In the classical zipper model for phagocytosis, the pseudopod extends over the IgG-coated particles, in which FCGRs in the phagocyte plasma membrane interact sequentially with Fc portions of IgG molecules zippering the membrane along the particle. This sequential IgG-FCGR binding might not occur by itself, but requires forced zipper closure, where myosin-II contractile activity may promote the binding between the FCGR and its ligands, to facilitate the efficient extension and subsequent closure of phagocytic cups (Araki 2006, ). Myosin IC mediates the purse-string-like contraction that closes phagosomes. Myosin-V has been implicated in membrane trafficking events (Swanson et al. 1999).
R-HSA-9670155 (Reactome) Wiskott-Aldrich syndrome protein (WASP) and Neural-WASP (N-WASP, WASL) proteins are scaffolds that transduce signals from cell surface receptors to the activation of the ARP2/3 complex and actin polymerization. WASP and N-WASP possess a central GTPase binding domain (GBD) and an NH2-terminal WASP homology domain 1 (WH1) followed by a basic region (B), and a C-terminal VCA region that contains: a V domain (verprolin homology/WASP homology 2), a C domain (connecting), and an A motif (acidic). The VCA region is responsible for binding to and activating the ARP2/3 complex (Bompard & Caron 2004, Callebaut et al 1998). Under resting conditions, WASP and N-WASP are maintained in an autoinhibited state via interaction of the GBD and the VCA domains. This prevents access of the ARP2/3 complex and G-actin to the VCA region. Activated CDC42 binds to the GBD region of WASPs and this interaction releases the VCA region from autoinhibition, enabling binding of the ARP2/3 complex and stimulating actin polymerization (Kim et al 2000, Park & Cox 2009). Phosphoinositides (PtdIns(4,5)P2) interact with the basic (B) region in WASPs and this interaction is important for activation of the WASPs and the ARP2/3 complex (Higgs & Pollard 2000).
R-HSA-9670156 (Reactome) Wiskott-Aldrich syndrome protein (WASP) and Neural-WASP (N-WASP, WASL) proteins are scaffolds that transduce signals from cell surface receptors to the activation of the ARP2/3 complex and actin polymerization. WASP and N-WASP possess a central GTPase binding domain (GBD) and an NH2-terminal WASP homology domain 1 (WH1) followed by a basic region (B), and a C-terminal VCA region that contains: a V domain (verprolin homology/WASP homology 2), a C domain (connecting), and an A motif (acidic). The VCA region is responsible for binding to and activating the ARP2/3 complex (Bompard & Caron 2004, Callebaut et al 1998). Under resting conditions, WASP and N-WASP are maintained in an autoinhibited state via interaction of the GBD and the VCA domains. This prevents access of the ARP2/3 complex and G-actin to the VCA region. Activated CDC42 binds to the GBD region of WASPs and this interaction releases the VCA region from autoinhibition, enabling binding of the ARP2/3 complex and stimulating actin polymerization (Kim et al 2000, Park & Cox 2009). Phosphoinositides (PtdIns(4,5)P2) interact with the basic (B) region in WASPs and this interaction is important for activation of the WASPs and the ARP2/3 complex (Higgs & Pollard 2000).
RAC1:GDPR-HSA-9666428 (Reactome)
RAC1:GDPR-HSA-9666430 (Reactome)
RAC1:GTPArrowR-HSA-9666428 (Reactome)
RAC1:GTPArrowR-HSA-9666430 (Reactome)
RAC1:GTPR-HSA-2029465 (Reactome)
SH3 domain proteinsR-HSA-2197691 (Reactome)
SYKR-HSA-9664273 (Reactome)
Src family kinases (SFKs)mim-catalysisR-HSA-9664261 (Reactome)
Src family kinases (SFKs)mim-catalysisR-HSA-9664275 (Reactome)
Src-kinasesmim-catalysisR-HSA-2197698 (Reactome)
Unknown GEFmim-catalysisR-HSA-2029445 (Reactome)
VAV1,2,3R-HSA-434637 (Reactome)
WASP/N-WASPR-HSA-442586 (Reactome)
WASP/N-WASPR-HSA-9670156 (Reactome)
WAVE Regulatory ComplexR-HSA-2029465 (Reactome)
WAVE2, WASP,

N-WASP:ARP2/3

complex:G-actin		ArrowR-HSA-442592 (Reactome)
WAVE2, WASP,

N-WASP:ARP2/3

complex:G-actin		R-HSA-2029466 (Reactome)
WAVE2, WASP, N-WASPArrowR-HSA-2197690 (Reactome)
WAVE2, WASP, N-WASPR-HSA-442592 (Reactome)
WIP family proteinsR-HSA-2197691 (Reactome)
WRC:IRSp53/58:RAC1:GTP:PIP3ArrowR-HSA-2029465 (Reactome)
WRC:IRSp53/58:RAC1:GTP:PIP3R-HSA-2130194 (Reactome)
p-T,Y MAPK dimersmim-catalysisR-HSA-2029469 (Reactome)
p-Y,S,T-WRC:IRSp53/58:RAC1:GTP:PIP3ArrowR-HSA-2029469 (Reactome)
p-Y-WRC:IRSp53/58:RAC1:GTP:PIP3ArrowR-HSA-2130194 (Reactome)
p-Y-WRC:IRSp53/58:RAC1:GTP:PIP3R-HSA-2029469 (Reactome)
Retrieved from "https://classic.wikipathways.org/index.php/Pathway:WP5000"
Personal tools